JPH0629246B2 - 2- (5-fluoronicotinoyl) acetic acid derivative and its salt - Google Patents

2- (5-fluoronicotinoyl) acetic acid derivative and its salt

Info

Publication number
JPH0629246B2
JPH0629246B2 JP60028397A JP2839785A JPH0629246B2 JP H0629246 B2 JPH0629246 B2 JP H0629246B2 JP 60028397 A JP60028397 A JP 60028397A JP 2839785 A JP2839785 A JP 2839785A JP H0629246 B2 JPH0629246 B2 JP H0629246B2
Authority
JP
Japan
Prior art keywords
general formula
salt
added
compound represented
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60028397A
Other languages
Japanese (ja)
Other versions
JPS61189269A (en
Inventor
洋三 藤堂
哲夫 山藤
勝之 南雲
功 北山
秀嘉 長木
三香子 品川
義憲 小西
弘和 成田
俊太郎 高野
勇 才川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to JP60028397A priority Critical patent/JPH0629246B2/en
Priority to AT72/86A priority patent/AT392789B/en
Priority to GB8601045A priority patent/GB2170804B/en
Priority to US06/819,821 priority patent/US4704459A/en
Priority to DE19863601517 priority patent/DE3601517A1/en
Priority to FI860250A priority patent/FI83313C/en
Priority to DE3641633A priority patent/DE3641633C2/en
Priority to DE3637679A priority patent/DE3637679C1/en
Priority to AU52543/86A priority patent/AU576657B2/en
Priority to CH235/86A priority patent/CH667456A5/en
Priority to NZ214901A priority patent/NZ214901A/en
Priority to NO860226A priority patent/NO163227C/en
Priority to FR868600871A priority patent/FR2576305B1/en
Priority to DK032286A priority patent/DK169570B1/en
Priority to NL8600138A priority patent/NL192986C/en
Priority to CH643/88A priority patent/CH671957A5/de
Priority to SE8600274A priority patent/SE462164B/en
Priority to ES551134A priority patent/ES8702362A1/en
Priority to CA000500107A priority patent/CA1340706C/en
Priority to BE0/216165A priority patent/BE904086A/en
Priority to CN 86100879 priority patent/CN1019012B/en
Priority to PT81889A priority patent/PT81889B/en
Priority to KR1019860000388A priority patent/KR880001078B1/en
Priority to PH33316A priority patent/PH22711A/en
Priority to IT47562/86A priority patent/IT1190193B/en
Priority to IL88468A priority patent/IL88468A/en
Priority to LU86264A priority patent/LU86264A1/en
Priority to IL9240186A priority patent/IL92401A/en
Priority to IL77688A priority patent/IL77688A/en
Publication of JPS61189269A publication Critical patent/JPS61189269A/en
Priority to ES557077A priority patent/ES8707730A1/en
Priority to ES557078A priority patent/ES8707715A1/en
Priority to PH35456A priority patent/PH22956A/en
Priority to PH35456A priority patent/PH23202A/en
Priority to US06/067,264 priority patent/US4851535A/en
Priority to CH642/88A priority patent/CH669378A5/en
Priority to GB8811645A priority patent/GB2204040B/en
Priority to CA 568266 priority patent/CA1340648C/en
Priority to CA000568265A priority patent/CA1340783C/en
Priority to SE8902265A priority patent/SE469984B/en
Priority to SE8902264A priority patent/SE469983B/en
Priority to FI893074A priority patent/FI85703C/en
Priority to FI893075A priority patent/FI87647C/en
Priority to NO892692A priority patent/NO174888C/en
Priority to NO892693A priority patent/NO167804C/en
Priority to AT2003/89A priority patent/AT392791B/en
Priority to AT0200289A priority patent/AT394193B/en
Priority to DK285290A priority patent/DK170532B1/en
Priority to DK285190A priority patent/DK170857B1/en
Priority to NO924181A priority patent/NO178574C/en
Publication of JPH0629246B2 publication Critical patent/JPH0629246B2/en
Priority to NL9700011A priority patent/NL193540C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明はグラム陽性菌およびグラム陰性菌に対して強力
な抗菌作用を示す、一般式 で表わされる1−アリール−1,4−ジヒドロ−4−オキ
ソナフチリジン誘導体およびその塩の重要な中間体であ
る一般式 で表わされる2−(5−フルオロニコチノイル)酢酸誘
導体およびその塩に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial application] The present invention has a general formula showing a strong antibacterial action against Gram-positive and Gram-negative bacteria. A 1-aryl-1,4-dihydro-4-oxonaphthyridine derivative represented by And a 2- (5-fluoronicotinoyl) acetic acid derivative and a salt thereof.

〔従来の技術〕[Conventional technology]

一般式(I)で表わされる1−アリール−1,4−ジヒド
ロ−4−オキソナフチリジン誘導体およびその塩は、第
24回インターサイエンス・コンフェランス・オン・ア
ンチミクロバイアル・エージェンツ・アンド・ケモセラ
ピー(Interscience Conference on Antimicrobial Age
nts and Chemotherapy)要旨集第102〜104頁および特公
昭63-20828号において、グラム陽性菌およびグラム陰性
菌に対して強い抗菌力を示し、経口または非経口投与に
より高い血中濃度を得ることができ、かつ安全性が高い
などの優れた性質を有することが示されている。しかし
これらの化合物を製造する方法として、一般式(II)で
表わされる2−(5−フルオロニコチノイル)酢酸誘導
体またはその塩を経由する方法は全く知られていない。
The 1-aryl-1,4-dihydro-4-oxonaphthyridine derivatives represented by the general formula (I) and salts thereof can be prepared according to the 24th Interscience Conference on Antimicrovial Agents and Chemotherapy (Interscience). Conference on Antimicrobial Age
nts and Chemotherapy), pages 102-104 and Japanese Patent Publication No. 63-20828, showing strong antibacterial activity against Gram-positive and Gram-negative bacteria and obtaining high blood concentration by oral or parenteral administration. It has been shown to have excellent properties such as being able to do and being highly safe. However, as a method for producing these compounds, a method via a 2- (5-fluoronicotinoyl) acetic acid derivative represented by the general formula (II) or a salt thereof is not known at all.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

本発明の目的は、一般式(I)で表わされる1−アリー
ル−1,4−ジヒドロ−4−オキソナフチリジン誘導体お
よびその塩を製造する際の有用な新規中間体を提供する
ことにある。
An object of the present invention is to provide a novel intermediate useful in the production of 1-aryl-1,4-dihydro-4-oxonaphthyridine derivatives represented by the general formula (I) and salts thereof.

〔問題点を解決するための手段〕[Means for solving problems]

かかる状況下において、本発明者らは鋭意研究した結
果、一般式(II)で表わされる2−(5−フルオロニコ
チノイル)酢酸誘導体およびその塩が、中間体として有
用であることを見出し、本発明を完成するに至つた。
Under such circumstances, the present inventors have conducted diligent research, and as a result, found that the 2- (5-fluoronicotinoyl) acetic acid derivative represented by the general formula (II) and its salt are useful as intermediates, The invention was completed.

以下、本発明を詳細に説明する。Hereinafter, the present invention will be described in detail.

本明細書中でR1およびR1aで示されるカルボキシル保護
形成基としては通常当該分野で使用されるもの、たとえ
ば、アルキル基、ベンジル基、ピバロイルオキシメチル
基、トリメチルシリル基などおよび特開昭59-80665号公
報などに記載された通常のカルボキシル基の保護基が挙
げられる。
As the carboxyl-protecting group represented by R 1 and R 1a in the present specification, those usually used in the art, for example, an alkyl group, a benzyl group, a pivaloyloxymethyl group, a trimethylsilyl group, and the like are disclosed. Examples thereof include the usual protecting groups for carboxyl groups described in JP-A-59-80665.

R2におけるハロゲン原子としては、たとえば、フッ素原
子、塩素原子、臭素原子、ヨウ素原子;アルコキシ基と
しては、たとえば、メトキシ、エトキシ、n−プロポキ
シ、イソブトキシ、ペンチルオキシ、ヘキシルオキシ、
ヘプチルオキシ、オクチルオキシ、ドデシルオキシな
ど;アルキルチオ基としては、たとえば、メチルチオ、
エチルチオ、n−プロピルチオ、イソブチルチオ、ペン
チルチオ、ヘキシルチオ、ヘプチルチオ、オクチルチ
オ、ドデシルチオなど;アリールチオ基としては、たと
えば、フエニルチオ、ナフチルチオなど;アルカンスル
ホニルオキシ基としては、たとえば、メタンスルホニル
オキシ、エタンスルホニルオキシ、1−メチルエタンス
ルホニルオキシ、1,1−ジメチルエタンスルホニルオキ
シなど;アレーンスルホニルオキシ基としては、たとえ
ば、ベンゼンスルホニルオキシ、ナフタレンスルホニル
オキシなどの基が挙げられる。
The halogen atom in R 2 is, for example, a fluorine atom, a chlorine atom, a bromine atom or an iodine atom; the alkoxy group is, for example, methoxy, ethoxy, n-propoxy, isobutoxy, pentyloxy, hexyloxy,
Heptyloxy, octyloxy, dodecyloxy and the like; examples of the alkylthio group include methylthio,
Ethylthio, n-propylthio, isobutylthio, pentylthio, hexylthio, heptylthio, octylthio, dodecylthio etc .; arylthio groups such as phenylthio, naphthylthio etc .; alkanesulfonyloxy groups such as methanesulfonyloxy, ethanesulfonyloxy, 1 -Methylethanesulfonyloxy, 1,1-dimethylethanesulfonyloxy and the like; Examples of the arenesulfonyloxy group include groups such as benzenesulfonyloxy and naphthalenesulfonyloxy.

上記したうち、アルコキシ、アルキルチオ、アリールチ
オ、アルカンスルホニルオキシおよびアレーンスルホニ
ルオキシ基は置換基を有していてもよく、これらの置換
基としては、たとえば、フッ素原子、塩素原子、臭素原
子、ヨウ素原子などのハロゲン原子;ニトロ基;メチ
ル、エチル、n−プロピル、イソプロピル、n−ブチ
ル、イソブチル、sec.−ブチル、tert.−ブチルなどの
アルキル基;メトキシ、エトキシ、n−プロポキシ、イ
ソプロポキシ、n−ブトキシ、イソブトキシ、sec.−ブ
トキシ、tert.−ブトキシなどのアルコキシ基などが挙
げられる。
Among the above, the alkoxy, alkylthio, arylthio, alkanesulfonyloxy and arenesulfonyloxy groups may have a substituent, and these substituents include, for example, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom and the like. A halogen atom; a nitro group; an alkyl group such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec.-butyl, tert.-butyl; methoxy, ethoxy, n-propoxy, isopropoxy, n- Alkoxy groups such as butoxy, isobutoxy, sec.-butoxy, tert.-butoxy and the like can be mentioned.

また、R2およびR3におけるアミノ基が保護されていても
よい3−アミノピロリジニル基およびイミノ基が保護さ
れていてもよいピペラジニル基におけるアミノ基および
イミノ基の保護基としては、通常当該分野で使用される
もの、たとえば、ホルミル、アセチルなどのアシル基な
どが挙げられる。
Further, as the amino group and the imino group-protecting group in the piperazinyl group, which may protect the 3-aminopyrrolidinyl group and the imino group, which may have the amino group in R 2 and R 3 protected, Examples include those used in the field, for example, acyl groups such as formyl and acetyl.

また、一般式(I)および(II)で表わされる化合物の
塩としては、通常知られているアミノ基、イミノ基など
の塩基性基またはカルボキシル基、ヒドロキシル基など
の酸性基における塩が挙げられる。
Examples of the salts of the compounds represented by the general formulas (I) and (II) include salts of commonly known basic groups such as amino groups and imino groups, or acidic groups such as carboxyl groups and hydroxyl groups. .

塩基性基における塩としては、たとえば、塩酸、臭化水
素酸、硫酸などの鉱酸との塩;シユウ酸、クエン酸、ト
ルフルオロ酢酸などの有機カルボン酸との塩;メタンス
ルホン酸、p−トルエンスルホン酸、ナフタレンスルホ
ン酸などのスルホン酸との塩を、酸性基における塩とし
ては、たとえば、ナトリウム、カリウムなどのアルカリ
金属との塩;カルシウム、マグネシウムなどのアルカリ
土類金属との塩;アンモニウム塩;プロカイン、ジベン
ジルアミン、N,N−ジベンジルエチレンジアミン、ト
リエチルアミン、ピリジン、N,N−ジメチルアニリ
ン、N−メチルピペリジン、ジエチルアミン、ジシクロ
ヘキシルアミンなどの含窒素有機塩基との塩を挙げるこ
とができる。
Examples of the salt in the basic group include salts with mineral acids such as hydrochloric acid, hydrobromic acid and sulfuric acid; salts with organic carboxylic acids such as oxalic acid, citric acid and trifluoroacetic acid; methanesulfonic acid, p-toluene. Examples of salts of acidic groups include salts with sulfonic acids such as sulfonic acid and naphthalene sulfonic acid; salts with alkaline metals such as sodium and potassium; salts with alkaline earth metals such as calcium and magnesium; ammonium salts. A salt with a nitrogen-containing organic base such as procaine, dibenzylamine, N, N-dibenzylethylenediamine, triethylamine, pyridine, N, N-dimethylaniline, N-methylpiperidine, diethylamine and dicyclohexylamine;

つぎに、本発明化合物の製造法について詳説する。Next, the method for producing the compound of the present invention will be described in detail.

一般式(II)で表わされる化合物またはその塩は、たと
えば、つぎの製造ルートに従つて製造することができ
る。
The compound represented by the general formula (II) or a salt thereof can be produced, for example, according to the following production route.

一般式(III)で表わされる化合物のカルボキシル基に
おける反応性誘導体としては、たとえば、酸クロリド、
酸ブロミドなどの酸ハロゲニド;酸無水物;炭酸モノエ
チルエステルなどとの混合酸無水物;ジニトロフエニル
エステル、シアノメチルエステル、スクシンイミドエス
テルなどの活性エステル;イミダゾールなどとの活性酸
アミドなどが挙げられる。
Examples of the reactive derivative at the carboxyl group of the compound represented by the general formula (III) include acid chloride,
Acid halides such as acid bromide; acid anhydrides; mixed acid anhydrides with carbonic acid monoethyl ester; active esters such as dinitrophenyl ester, cyanomethyl ester, succinimide ester; active acid amides with imidazole, etc. .

また、一般式(IV)および(V)で表わされる化合物の
塩としては、たとえば、リチウム、カリウム、ナトリウ
ムなどのアルカリ金属との塩;マグネシウムなどのアル
カリ土類金属との塩;エトキシマグネシウムとの塩など
が挙げられる。
Examples of salts of the compounds represented by the general formulas (IV) and (V) include salts with alkali metals such as lithium, potassium and sodium; salts with alkaline earth metals such as magnesium; and ethoxymagnesium. Examples include salt.

また、一般式(VI)で表わされる化合物の塩としては、
一般式(I)および(II)で表わされる化合物の塩で説
明したと同様の塩が挙げられる。
Further, as the salt of the compound represented by the general formula (VI),
The same salts as described for the salts of the compounds represented by the general formulas (I) and (II) can be mentioned.

一般式(II)または(VI)で表わされる化合物もしくは
それらの塩は通常適当な溶媒中、一般式(III)で表わ
される化合物のカルボキシル基における反応性誘導体
に、それぞれ一般式(V)または(IV)で表わされる化
合物もしくはそれらの塩を反応させることによつて得る
ことができる。使用される溶媒としては、反応に悪影響
を与えないものであれば特に限定されないが、具体的に
は、水;メタノール、エタノール、2−プロパノールな
どのアルコール類;ベンゼン、トルエンなどの芳香族炭
化水素類;塩化メチレン、クロロホルム、ジクロロエタ
ンなどのハロゲン化炭化水素類;ジエチルエーテル、テ
トラヒドロフラン、ジオキサンなどのエーテル類;アセ
トニトリルなどのニトリル酸;N,N−ジメチルホルム
アミド、N,N−ジメチルアセトアミドなどのアミド類
などが挙げられる。また、一般式(IV)または(V)で
表わされる化合物もしくはそれらの塩の使用量は、それ
ぞれ一般式(III)で表わされる化合物のカルボキシル
基における反応性誘導体に対して等モル以上、好ましく
は1.0〜2.5倍モルである。本反応は通常−50〜100℃、
好ましくは−20〜70℃で、5分〜30時間実施すればよ
い。
The compound represented by the general formula (II) or (VI) or a salt thereof is usually added to a reactive derivative at the carboxyl group of the compound represented by the general formula (III) in a suitable solvent, respectively. It can be obtained by reacting a compound represented by IV) or a salt thereof. The solvent used is not particularly limited as long as it does not adversely affect the reaction, and specifically, water; alcohols such as methanol, ethanol and 2-propanol; aromatic hydrocarbons such as benzene and toluene. Halogenated hydrocarbons such as methylene chloride, chloroform and dichloroethane; Ethers such as diethyl ether, tetrahydrofuran and dioxane; Nitric acid such as acetonitrile; Amides such as N, N-dimethylformamide and N, N-dimethylacetamide And so on. The amount of the compound represented by the general formula (IV) or (V) or a salt thereof used is at least equimolar to the reactive derivative at the carboxyl group of the compound represented by the general formula (III), preferably It is 1.0 to 2.5 times the molar amount. This reaction is usually -50 to 100 ° C,
Preferably, it is carried out at -20 to 70 ° C for 5 minutes to 30 hours.

一般式(VI)で表わされる化合物またはその塩を一般式
(II)で表わされる化合物またはその塩に誘導するに
は、一般式(VI)で表わされる化合物またはその塩を、
たとえば、含水溶媒中p−トルエンスルホン酸またはア
ニソール中トリフルオロ酢酸を用いて部分的にカルボキ
シル保護形成基を脱離および脱カルボキシル化すればよ
い。
To derive the compound represented by the general formula (VI) or a salt thereof into the compound represented by the general formula (II) or a salt thereof, the compound represented by the general formula (VI) or a salt thereof is
For example, p-toluenesulfonic acid in a water-containing solvent or trifluoroacetic acid in anisole may be used to partially eliminate and decarboxylate the carboxyl-protecting group.

また、一般式(II)で表わされる化合物またはその塩に
おいて、R2がヒドロキシル基またはハロゲン原子である
場合は、つぎに示す方法によつて他の本発明化合物へ導
くこともできる。
Further, in the compound represented by the general formula (II) or a salt thereof, when R 2 is a hydroxyl group or a halogen atom, it can be led to another compound of the present invention by the following method.

また、一般式(VII)で表わされる化合物の塩として
は、一般式(I)および(II)で表わされる化合物の酸
性基における塩で説明したと同様の塩が、さらに一般式
(VIII)で表わされる化合物の塩としては、一般式
(I)および(II)で表わされる化合物の塩基性基にお
ける塩で説明したと同様の塩が挙げられる。
Further, as the salt of the compound represented by the general formula (VII), the same salts as those described for the salt in the acidic group of the compounds represented by the general formulas (I) and (II) can be further represented by the general formula (VIII). Examples of the salt of the compound represented include the same salts as those described for the salt in the basic group of the compounds represented by formulas (I) and (II).

(1)一般式(IIb)で表わされる化合物の製法(アルキル
化) 一般式(IIb)で表わされる化合物は、一般式(IIa)で
表わされる化合物またはその塩をアルキル化反応に付す
ことにより得ることができる。使用されるアルキル化剤
としては特に限定されないが、好ましいものとして、ジ
アゾアルカン、硫酸ジアルキルおよびハロゲン化アルキ
ルなどが挙げられる。
(1) Method for producing compound represented by general formula (IIb) (alkylation) The compound represented by general formula (IIb) is obtained by subjecting a compound represented by general formula (IIa) or a salt thereof to an alkylation reaction. be able to. The alkylating agent used is not particularly limited, but preferred examples include diazoalkanes, dialkyl sulfates and alkyl halides.

(イ)ジアゾアルカンによるアルキル化 一般式(IIb)で表わされる化合物は、一般式(IIa)で
表わされる化合物またはその塩にジアゾアルカンを反応
させることによつて得ることができる。本反応を溶媒中
で行う場合、使用される溶媒としては、反応に悪影響を
与えないものであれば特に限定されないが、具体的に
は、メタノール、エタノール、2−プロパノールなどの
アルコール類;ジエチルエーテル、テトラヒドロフラ
ン、ジオキサンなどのエーテル類;アセトン、メチルエ
チルケトンなどのケトン類;酢酸メチル、酢酸エチルな
どのエステル類;ベンゼン、トルエンなどの芳香族炭化
水素類などが挙げられる。これらの溶媒を2種若しくは
それ以上混合して使用してもよい。ジアゾアルカンとし
ては、たとえば、ジアゾメタン、ジアゾエタンなどが挙
げられ、その使用量は、一般式(IIa)で表わされる化
合物に対して等モル以上、好ましくは1.0〜1.5倍モルで
ある。本反応は通常0〜50℃、好ましくは0〜25℃
で、5分〜30時間実施すればよい。
(A) Alkylation with diazoalkane The compound represented by the general formula (IIb) can be obtained by reacting the compound represented by the general formula (IIa) or a salt thereof with a diazoalkane. When this reaction is carried out in a solvent, the solvent used is not particularly limited as long as it does not adversely affect the reaction, and specifically, alcohols such as methanol, ethanol and 2-propanol; diethyl ether. , Ethers such as tetrahydrofuran and dioxane; ketones such as acetone and methyl ethyl ketone; esters such as methyl acetate and ethyl acetate; aromatic hydrocarbons such as benzene and toluene. You may use these solvents in mixture of 2 or more types. Examples of the diazoalkane include diazomethane, diazoethane and the like, and the use amount thereof is equimolar or more, preferably 1.0 to 1.5 times the molar amount of the compound represented by the general formula (IIa). This reaction is generally 0 to 50 ° C, preferably 0 to 25 ° C.
Then, it may be carried out for 5 minutes to 30 hours.

(ロ)硫酸ジアルキルによるアルキル化 一般式(IIb)で表わされる化合物は一般式(IIa)で表
わされる化合物またはその塩に、脱酸剤の存在下または
不存在下、硫酸ジアルキルを反応させることによつて得
ることができる。本反応を溶媒中で行う場合、使用され
る溶媒としては、反応に悪影響を与えないものであれば
特に限定されないが、具体的には、水;アセトン、メチ
ルエチルケトンなどのケトン類;酢酸メチル、酢酸エチ
ルなどのエステル類;テトラヒドロフラン、ジオキサン
などのエーテル類;N,N−ジメチルホルムアミド、
N,N−ジメチルアセトアミドなどのアミド類;ジメチ
ルスルホキシドなどのスルホキシド類などが挙げられ
る。これらの溶媒を2種若しくはそれ以上混合して使用
してもよい。硫酸ジアルキルとしては、たとえば、硫酸
ジメチル、硫酸ジエチルなどが挙げられる。脱酸剤とし
ては、たとえば、水酸化アルカリ、炭酸アルカリなどの
無機塩基が挙げられる。
(B) Alkylation with dialkyl sulfate A compound represented by the general formula (IIb) is obtained by reacting a compound represented by the general formula (IIa) or a salt thereof with a dialkyl sulfate in the presence or absence of a deoxidizing agent. You can get it. When this reaction is carried out in a solvent, the solvent used is not particularly limited as long as it does not adversely affect the reaction, and specifically, water; ketones such as acetone and methyl ethyl ketone; methyl acetate, acetic acid Esters such as ethyl; ethers such as tetrahydrofuran and dioxane; N, N-dimethylformamide,
Examples thereof include amides such as N, N-dimethylacetamide; sulfoxides such as dimethyl sulfoxide. You may use these solvents in mixture of 2 or more types. Examples of the dialkyl sulfate include dimethyl sulfate and diethyl sulfate. Examples of the deoxidizing agent include inorganic bases such as alkali hydroxide and alkali carbonate.

本反応において硫酸ジアルキルおよび所望に応じて使用
される脱酸剤の使用量は、一般式(IIa)で表わされる
化合物またはその塩に対してそれぞれ等モル以上、好ま
しくは1〜2倍モルである。本反応は通常0〜150℃、
好ましくは0〜50℃で、5分〜30時間実施すればよ
い。
In this reaction, the amount of the dialkyl sulfate and optionally a deoxidizing agent used is equimolar or more, preferably 1 to 2 times the molar amount of the compound represented by the general formula (IIa) or a salt thereof. . This reaction is usually 0 ~ 150 ℃,
Preferably, it may be carried out at 0 to 50 ° C. for 5 minutes to 30 hours.

(ハ)ハロゲン化アルキルによるアルキル化 一般式(IIb)で表わされる化合物は、脱酸剤の存在下
または不存在下、一般式(IIa)で表わされる化合物ま
たはその塩にハロゲン化アルキルを反応させることによ
つて得ることができる。本反応を溶媒中で行う場合、使
用される溶媒としては、反応に悪影響を与えないもので
あれば特に限定されないが、具体的には、水;塩化メチ
レン、クロロホルムなどのハロゲン化炭化水素類;ジエ
チルエーテル、テトラヒドロフラン、ジオキサンなどの
エーテル類;N,N−ジメチルホルムアミド、N,N−
ジメチルアセトアミドなどのアミド類;ジメチルスルホ
キシドなどのスルホキシド類などが挙げられる。これら
の溶媒は2種若しくはそれ以上混合して使用してもよ
い。ハロゲン化アルキルとしては、たとえば、ヨウ化メ
チル、臭化メチル、臭化エチルなどが挙げられる。脱酸
剤としては、たとえば、炭酸アルカリなどの無機塩基、
またはトリメチルアミン、トリエチルアミン、トリブチ
ルアミン、ピリジン、N−メチルピペリジン、N−メチ
ルモルホリン、ルチジン、コリジンなどの有機塩基が挙
げられる。
(C) Alkylation with an alkyl halide The compound represented by the general formula (IIb) is obtained by reacting the compound represented by the general formula (IIa) or a salt thereof with an alkyl halide in the presence or absence of a deoxidizing agent. It can be obtained. When this reaction is carried out in a solvent, the solvent used is not particularly limited as long as it does not adversely affect the reaction, and specifically, water; halogenated hydrocarbons such as methylene chloride and chloroform; Ethers such as diethyl ether, tetrahydrofuran, dioxane; N, N-dimethylformamide, N, N-
Examples thereof include amides such as dimethylacetamide; sulfoxides such as dimethyl sulfoxide. You may use these solvents in mixture of 2 or more types. Examples of the alkyl halide include methyl iodide, methyl bromide, ethyl bromide and the like. As the deoxidizer, for example, an inorganic base such as alkali carbonate,
Alternatively, organic bases such as trimethylamine, triethylamine, tributylamine, pyridine, N-methylpiperidine, N-methylmorpholine, lutidine, collidine and the like can be mentioned.

本反応において、ハロゲン化アルキルおよび所望に応じ
て使用される脱酸剤の使用量は、一般式(IIa)で表わ
される化合物またはその塩に対してそれぞれ等モル以
上、好ましくは1〜2倍モルである。本反応は通常0〜
150℃、好ましくは0〜50℃で、5分〜30時間実施
すればよい。
In this reaction, the amount of the alkyl halide and the deoxidizing agent optionally used is equimolar or more, preferably 1 to 2 times the molar amount of the compound represented by the formula (IIa) or a salt thereof. Is. This reaction is usually 0
It may be carried out at 150 ° C, preferably 0 to 50 ° C, for 5 minutes to 30 hours.

(2)一般式(IIc)で表わされる化合物の製法(スルホニ
ル化) 一般式(IIc)で表わされる化合物は、一般式(IIa)で
表わされる化合物またはその塩に、脱酸剤の存在下また
は不存在下、スルホニル化剤を反応させることによつて
得ることができる。
(2) Method for producing compound represented by general formula (IIc) (sulfonylation) The compound represented by general formula (IIc) is obtained by reacting a compound represented by general formula (IIa) or a salt thereof with a deoxidizing agent or It can be obtained by reacting a sulfonylating agent in the absence.

本反応を溶媒中で行う場合、使用される溶媒としては、
反応に悪影響を与えないものであれば特に限定されない
が、具体的には、水;ベンゼン、トルエン、キシレンな
どの芳香族炭化水素類;ジオキサン、テトラヒドロフラ
ン、アニソール、ジエチレングリコールジメチルエーテ
ルなどのエーテル類;塩化メチレン、クロロホルム、ジ
クロロエタンなどのハロゲン化炭化水素類;アセトン、
メチルエチルケトンなどのケトン類;N,N−ジメチル
ホルムアミド、N,N−ジメチルアセトアミドなどのア
ミド類;ジメチルスルホキシドなどのスルホキシド類;
ヘキサメチルホスホルアミド;ピリジンなどが挙げられ
る。これらの溶媒は2種若しくはそれ以上混合して使用
してもよい。スルホニル化剤としては、たとえば、メタ
ンスルホニルクロリド、エタンスルホニルクロリド、1
−メチルエタンスルホニルクロリド、1,1−ジメチルエ
タンスルホニルクロリドなどのアルカンスルホニルハロ
ゲニド類、ベンゼンスルホニルクロリド、トルエンスル
ホニルクロリド、2−ニトロベンゼンスルホニルクロリ
ド、メシチレンスルホニルクロリド、2,4,6−トリイソ
プロピルベンゼンスルホニルクロリド、ナフタレンスル
ホニルクロリドなどのアレーンスルホニルハロゲニド
類、ベンゼンスルホン酸無水物、トルエンスルホン酸無
水物、メタンスルホン酸無水物などのアルカン−または
アレーン−スルホン酸無水物などが挙げられる。脱酸剤
としては、たとえば、トリエチルアミン、ジイソプロピ
ルエチルアミン、1,8−ジアザビシクロ−〔5.4.0〕−ウ
ンデセ−7−エン(DBU)、ピリジン、カリウムter
t.−ブトキシド、炭酸カリウム、炭酸ナトリウム、水素
化ナトリウムなどの有機または無機塩基が挙げられる。
When this reaction is carried out in a solvent, the solvent used is
It is not particularly limited as long as it does not adversely affect the reaction, and specifically, water; aromatic hydrocarbons such as benzene, toluene, xylene; ethers such as dioxane, tetrahydrofuran, anisole, diethylene glycol dimethyl ether; methylene chloride , Halogenated hydrocarbons such as chloroform, dichloroethane; acetone,
Ketones such as methyl ethyl ketone; amides such as N, N-dimethylformamide and N, N-dimethylacetamide; sulfoxides such as dimethyl sulfoxide;
Hexamethylphosphoramide; pyridine and the like. You may use these solvents in mixture of 2 or more types. Examples of the sulfonylating agent include methanesulfonyl chloride, ethanesulfonyl chloride, 1
-Methylethanesulfonyl chloride, alkanesulfonyl halides such as 1,1-dimethylethanesulfonyl chloride, benzenesulfonyl chloride, toluenesulfonyl chloride, 2-nitrobenzenesulfonyl chloride, mesitylenesulfonyl chloride, 2,4,6-triisopropylbenzenesulfonyl Examples thereof include arenesulfonyl halogenides such as chloride and naphthalenesulfonyl chloride, alkane- or arene-sulfonic anhydride such as benzenesulfonic anhydride, toluenesulfonic anhydride and methanesulfonic anhydride. Examples of the deoxidizing agent include triethylamine, diisopropylethylamine, 1,8-diazabicyclo- [5.4.0] -undec-7-ene (DBU), pyridine and potassium ter.
Organic or inorganic bases such as t.-butoxide, potassium carbonate, sodium carbonate, sodium hydride and the like.

スルホニル化剤および所望に応じて使用される脱酸剤の
使用量は、一般式(IIa)で表わされる化合物またはそ
の塩に対してそれぞれ等モル以上、好ましくは1〜2倍
モルである。本反応は通常−10〜150℃、好ましくは0
〜80℃で、5分〜30時間実施すればよい。
The amount of the sulfonylating agent and the deoxidizing agent used as required is equimolar or more, preferably 1 to 2 times the molar amount of the compound represented by the formula (IIa) or a salt thereof. This reaction is generally -10 to 150 ° C, preferably 0.
It may be carried out at -80 ° C for 5 minutes to 30 hours.

(3)一般式(IId)で表わされる化合物の製法(チオール
化) 一般式(IId)で表わされる化合物は、一般式(IIc)ま
たは(IIe)で表わされる化合物に、脱酸剤の存在下ま
たは不存在下、一般式(VII)で表わされるチオール類
またはその塩を反応させることによつて得ることができ
る。
(3) Method for producing compound represented by general formula (IId) (thiolation) The compound represented by general formula (IId) is obtained by reacting a compound represented by general formula (IIc) or (IIe) with a deoxidizing agent. Alternatively, it can be obtained by reacting a thiol represented by the general formula (VII) or a salt thereof in the absence thereof.

本反応を溶媒中で行う場合、使用される溶媒としては、
反応に悪影響を与えないものであれば特に限定されない
が、具体的には、ベンゼン、トルエン、キシレンなどの
芳香族炭化水素類;ジオキサン、テトラヒドロフラン、
アニソール、ジエチレングリコールジエチルエーテルな
どのエーテル類;塩化メチレン、クロロホルム、ジクロ
ロエタンなどのハロゲン化炭化水素類;N,N−ジメチ
ルホルムアミド、N,N−ジメチルアセトアミドなどの
アミド類;ジメチルスルホキシドなどのスルホキシド類
などが挙げられる。これらの溶媒は2種若しくはそれ以
上混合して使用してもよい。
When this reaction is carried out in a solvent, the solvent used is
It is not particularly limited as long as it does not adversely affect the reaction, and specifically, aromatic hydrocarbons such as benzene, toluene and xylene; dioxane, tetrahydrofuran,
Ethers such as anisole and diethylene glycol diethyl ether; halogenated hydrocarbons such as methylene chloride, chloroform and dichloroethane; amides such as N, N-dimethylformamide and N, N-dimethylacetamide; sulfoxides such as dimethyl sulfoxide Can be mentioned. You may use these solvents in mixture of 2 or more types.

一般式(VII)で表わされるチオール類としては、たと
えば、メタンチオール、エタンチオール、n−プロパン
チオール、イソブタンチオール、ペンタンチオール、ヘ
キサンチオール、ヘプタンチオール、オクタンチオー
ル、ドデカンチオール、チオフエノール、ナフタレンチ
オールなどが挙げられる。脱酸剤としては、(2)で挙げ
たと同様の無機または有機塩基が挙げられる。
Examples of the thiols represented by the general formula (VII) include methanethiol, ethanethiol, n-propanethiol, isobutanethiol, pentanethiol, hexanethiol, heptanethiol, octanethiol, dodecanethiol, thiophenol and naphthalenethiol. Is mentioned. Examples of the deoxidizing agent include the same inorganic or organic bases as those mentioned in (2).

一般式(VII)で表わされるチオール類またはその塩お
よび所望に応じて使用される脱酸剤の使用量は、一般式
(IIc)または(IIe)で表わされる化合物に対してそれ
ぞれ等モル以上、好ましくは1〜2倍モルである。本反
応は通常0〜150℃、好ましくは0〜70℃で、5分〜3
0時間実施すればよい。
The amount of the thiol represented by the general formula (VII) or a salt thereof and the deoxidizing agent optionally used is equimolar or more with respect to the compound represented by the general formula (IIc) or (IIe), The molar amount is preferably 1 to 2 times. This reaction is usually at 0 to 150 ° C, preferably at 0 to 70 ° C for 5 minutes to 3
It may be carried out for 0 hours.

(4)一般式(IIf)で表わされる化合物またはその塩の製
法 一般式(IIf)で表わされる化合物またはその塩は、一
般式(IIc)または(IIe)で表わされる化合物に、脱酸
剤の存在下または不存在下に、一般式(VIII)で表わさ
れるアミン類またはその塩を反応させることによつて得
ることができる。
(4) Method for producing a compound represented by the general formula (IIf) or a salt thereof A compound represented by the general formula (IIf) or a salt thereof is prepared by adding a deoxidizing agent to a compound represented by the general formula (IIc) or (IIe). It can be obtained by reacting an amine represented by the general formula (VIII) or a salt thereof in the presence or absence.

本反応を溶媒中で行う場合、使用される溶媒としては、
反応に悪影響を与えないものであれば特に限定されない
が、具体的には、ベンゼン、トルエン、キシレンなどの
芳香族炭化水素類;メタノール、エタノール、n−プロ
パノール、2−プロパノール、n−ブタノール、イソブ
タノール、tert.−ブタノールなどのアルコール類;ジ
オキサン、テトラヒドロフラン、アニソール、ジエチレ
ングリコールなどのエーテル類;塩化メチレン、クロロ
ホルム、ジクロロエタンなどのハロゲン化炭化水素類;
N,N−ジメチルホルムアミド、N,N−ジメチルアセ
トアミドなどのアミド類;ジメチルスルホキシドなどの
スルホキシド類などが挙げられる。これらの溶媒は2種
若しくはそれ以上混合して使用してもよい。また、脱酸
剤としては、(2)で挙げたと同様の無機または有機塩基
が挙げられる。
When this reaction is carried out in a solvent, the solvent used is
It is not particularly limited as long as it does not adversely affect the reaction, but specifically, aromatic hydrocarbons such as benzene, toluene and xylene; methanol, ethanol, n-propanol, 2-propanol, n-butanol, iso Alcohols such as butanol and tert.-butanol; ethers such as dioxane, tetrahydrofuran, anisole and diethylene glycol; halogenated hydrocarbons such as methylene chloride, chloroform and dichloroethane;
Examples thereof include amides such as N, N-dimethylformamide and N, N-dimethylacetamide; and sulfoxides such as dimethyl sulfoxide. You may use these solvents in mixture of 2 or more types. Moreover, as the deoxidizing agent, the same inorganic or organic bases as those mentioned in (2) can be mentioned.

一般式(VIII)で表わされるアミン類またはその塩の使
用量は脱酸剤を用いない場合、一般式(IIc)または(I
Ie)で表わされる化合物に対して、好ましくは2〜5倍
モルであるが、脱酸剤を適宜使用することによつて一般
式(VIII)で表わされるアミン類またはその塩の使用量
を減らすことができる。本反応は通常0〜150℃、好ま
しくは15〜100℃で、5分〜30時間実施すればよ
い。
The amount of the amine represented by the general formula (VIII) or a salt thereof used in the general formula (IIc) or (I
The amount is preferably 2 to 5 times the molar amount of the compound represented by Ie), but the amount of the amines represented by the general formula (VIII) or a salt thereof can be reduced by appropriately using a deoxidizing agent. be able to. This reaction may be carried out usually at 0 to 150 ° C., preferably 15 to 100 ° C. for 5 minutes to 30 hours.

また、本発明化合物を製造するための原料である一般式
(III)で表わされる化合物は、たとえば、つぎのよう
にして得ることができる。
The compound represented by the general formula (III), which is a raw material for producing the compound of the present invention, can be obtained, for example, as follows.

また、上記式(IIIa)〜(IIIe)、(IX)、(XI)およ
び(XII)における化合物の塩としては、一般式(I)
および(II)で表わされる化合物で説明したと同様の塩
が挙げられる。
Further, the salts of the compounds represented by the above formulas (IIIa) to (IIIe), (IX), (XI) and (XII) can be represented by the general formula (I)
And the salts similar to those described for the compound represented by (II).

一般式(XI)で表わされる化合物またはその塩は、英国
特許第1409987号に記載の方法に準じて一般式(IX)で
表わされる化合物またはその塩に一般式(X)で表わさ
れる化合物を反応させることによつて得ることができ
る。
A compound represented by the general formula (XI) or a salt thereof is obtained by reacting a compound represented by the general formula (IX) or a salt thereof with a compound represented by the general formula (X) according to the method described in British Patent No. 1409987. Can be obtained.

また、一般式(XII)で表わされる化合物またはその塩
は、ブレタン・ド・ラ・ソシエテ・シミク・ドゥ・フラ
ンス(Bull.Soc.Chim,Fr.)1165〜1169(1975)に記載の方
法に従つて製造することができる。
In addition, the compound represented by the general formula (XII) or a salt thereof is prepared by the method described in Bulletin de la Societe Simique de France (Bull.Soc.Chim, Fr.) 1165 to 1169 (1975). Therefore, it can be manufactured.

一般式(IIIa)で表わされる化合物またはその塩は、縮
合剤の存在下または不存在下、一般式(XI)で表わされ
る化合物またはその塩に、一般式(XII)で表わされる
化合物またはその塩を反応させることによつて得ること
ができる。
A compound represented by the general formula (IIIa) or a salt thereof can be obtained by converting a compound represented by the general formula (XI) or a salt thereof into a compound represented by the general formula (XII) or a salt thereof in the presence or absence of a condensing agent. Can be obtained by reacting

本反応を溶媒中で行う場合、使用される溶媒としては、
反応に悪影響を与えないものであれば特に限定されない
が、具体的には、水;メタノール、エタノール、2−プ
ロパノール、ブタノール、エチレングリコール、メチル
セロソルブなどのアルコール類;ベンゼン、トルエンな
どの芳香族炭化水素類;塩化メチレン、クロロホルム、
ジクロロエタンなどのハロゲン化炭化水素類;テトラヒ
ドロフラン、ジオキサン、アニソール、ジエチレングリ
コールジメチルエーテル、ジメチルセロソルブなどのエ
ーテル類;アセトニトリルなどのニトリル類;アセト
ン、メチルエチルケトンなどのケトン類;酢酸エチル、
酢酸メチルなどのエステル類;N,N−ジメチルホルム
アミド、N,N−ジメチルアセトアミドなどのアミド
類;ジメチルスルホキシドなどのスルホキシド類などが
挙げられる。これらの溶媒を2種若しくはそれ以上混合
して使用してもよい。
When this reaction is carried out in a solvent, the solvent used is
It is not particularly limited as long as it does not adversely affect the reaction, and specifically, water; alcohols such as methanol, ethanol, 2-propanol, butanol, ethylene glycol, methyl cellosolve; aromatic carbonization such as benzene and toluene. Hydrogens; methylene chloride, chloroform,
Halogenated hydrocarbons such as dichloroethane; ethers such as tetrahydrofuran, dioxane, anisole, diethylene glycol dimethyl ether, dimethyl cellosolve; nitriles such as acetonitrile; ketones such as acetone and methyl ethyl ketone; ethyl acetate,
Examples thereof include esters such as methyl acetate; amides such as N, N-dimethylformamide and N, N-dimethylacetamide; sulfoxides such as dimethyl sulfoxide. You may use these solvents in mixture of 2 or more types.

縮合剤としては、たとえば、水酸化ナトリウム、水酸化
カリウム、カリウムtert.−ブトキシド、水素化ナトリ
ウム、ナトリウムメトキシド、ナトリウムエトキシド、
カリウムメトキシド、カリウムエトキシドなどが挙げら
れる。
As the condensing agent, for example, sodium hydroxide, potassium hydroxide, potassium tert.-butoxide, sodium hydride, sodium methoxide, sodium ethoxide,
Examples thereof include potassium methoxide and potassium ethoxide.

本反応において、一般式(XII)で表わされる化合物ま
たはその塩の使用量は、特に限定されないが、通常、一
般式(XI)で表わされる化合物またはその塩に対して等
モル以上、好ましくは1.0〜3.0倍モルである。また、
本反応は通常0〜150℃、好ましくは25〜100℃で、5
分〜30時間実施すればよい。
In this reaction, the amount of the compound represented by the general formula (XII) or a salt thereof is not particularly limited, but is usually equimolar or more, preferably 1 mol or more with respect to the compound represented by the general formula (XI) or a salt thereof. It is 0.0 to 3.0 times mol. Also,
This reaction is usually performed at 0 to 150 ° C, preferably 25 to 100 ° C, and
It may be carried out for a minute to 30 hours.

また、アルキル化、スルホニル化、チオール化および一
般式(IIIc)で表わされる化合物またはその塩を一般式
(IIIe)で表わされる化合物またはその塩へ誘導する方
法は前述したと同様の方法によつて行うことができる。
Further, the alkylation, sulfonylation, thiolation and the method of deriving the compound represented by the general formula (IIIc) or a salt thereof into the compound represented by the general formula (IIIe) or a salt thereof can be carried out by the same method as described above. It can be carried out.

また、一般式(IIIc)で表わされる化合物またはその塩
のうち、R10がハロゲン原子である場合は、一般式(III
a)で表わされる化合物またはその塩にハロゲン化剤を
反応させることによつて得ることができる。この反応を
溶媒中で行う場合、使用される溶媒としては、反応に悪
影響を与えないものであれば特に限定されないが、具体
的には、ベンゼン、トルエン、キシレンなどの芳香族炭
化水素類;塩化メチレン、クロロホルム、ジクロロエタ
ンなどのハロゲン化炭化水素類;N,N−ジメチルホル
ムアミド、N,N−ジメチルアセトアミドなどのアミド
類などが挙げられる。これらの溶媒は2種若しくはそれ
以上混合して使用してもよい。ハロゲン化剤としては、
たとえば、オキシ塩化リン、オキシ臭化リン、五塩化リ
ン、五臭化リン、三塩化リン、塩化チオニル、ホスゲン
などが挙げられ、これらの試剤を2種若しくはそれ以上
混合して使用してもよく、これらのハロゲン化剤は溶媒
として用いてもよい。ハロゲン化剤の使用量は、一般式
(IIIa)で表わされる化合物またはその塩に対して等モ
ル以上である。本反応は通常0〜150℃、好ましくは5
0〜110℃で、30分〜30時間実施すればよい。
In the compound represented by the general formula (IIIc) or a salt thereof, when R 10 is a halogen atom, the compound represented by the general formula (IIIc
It can be obtained by reacting the compound represented by a) or a salt thereof with a halogenating agent. When this reaction is carried out in a solvent, the solvent used is not particularly limited as long as it does not adversely affect the reaction, and specifically, aromatic hydrocarbons such as benzene, toluene, xylene; Halogenated hydrocarbons such as methylene, chloroform and dichloroethane; amides such as N, N-dimethylformamide and N, N-dimethylacetamide. You may use these solvents in mixture of 2 or more types. As a halogenating agent,
Examples thereof include phosphorus oxychloride, phosphorus oxybromide, phosphorus pentachloride, phosphorus pentabromide, phosphorus trichloride, thionyl chloride, phosgene, etc. These agents may be used as a mixture of two or more kinds. These halogenating agents may be used as a solvent. The amount of the halogenating agent used is equimolar or more based on the compound represented by the general formula (IIIa) or a salt thereof. This reaction is usually 0 to 150 ° C, preferably 5
It may be carried out at 0 to 110 ° C. for 30 minutes to 30 hours.

このようにして得られた一般式(IIIa)〜(IIIe)で表
わされる化合物またはそれらの塩は、自体公知の方法に
より、一般式(III)で表わされる化合物のカルボキシ
ル基における反応性誘導体へ変換することができる。
The compounds represented by the general formulas (IIIa) to (IIIe) or salts thereof thus obtained are converted into a reactive derivative at the carboxyl group of the compound represented by the general formula (III) by a method known per se. can do.

以上説明したそれぞれの反応によつて得られる化合物は
常法によつて単離または分離することができ、また単離
または分離することなくつぎの反応に使用することもで
きる。
The compound obtained by each of the reactions described above can be isolated or separated by a conventional method, or can be used in the next reaction without isolation or separation.

このようにして得られた一般式(II)で表わされる化合
物またはその塩は、たとえば、つぎに示すルートによつ
て一般式(I)で表わされる化合物またはその塩へ誘導
することができる。
The thus-obtained compound represented by the general formula (II) or a salt thereof can be derived into the compound represented by the general formula (I) or a salt thereof by the route shown below, for example.

上述した工程において、一般式(XIII)で表わされる化
合物またはその塩のR2がヒドロキシル基または置換基を
有していてもよいアルコキシ基の場合は、これをたとえ
ば、R2が対応するハロゲン原子あるいは置換基を有して
いてもよいアルカンスルホニルオキシまたはアレーンス
ルホニルオキシ基である一般式(XIII)で表わされる化
合物またはその塩に変換した後、一般式(VIII)で表わ
される化合物またはその塩を作用させ、一般式(I)で
表わされる化合物またはその塩へ誘導することができ
る。また、一般式(XIII)で表わされる化合物またはそ
の塩のR2が置換基を有していてもよいアルキルチオまた
はアリールチオの場合は、これをR2が対応するスルホキ
シまたはスルホンである一般式(XIII)で表わされる化
合物またはその塩に変換した後、一般式(VIII)で表わ
される化合物またはその塩を作用させ、一般式(I)で
表わされる化合物またはその塩に誘導することができ
る。
In the above-mentioned steps, when R 2 of the compound represented by the general formula (XIII) or a salt thereof is a hydroxyl group or an alkoxy group which may have a substituent, this may be, for example, a halogen atom to which R 2 corresponds. Alternatively, the compound represented by the general formula (VIII) or a salt thereof is converted to a compound represented by the general formula (XIII) or a salt thereof, which is an alkanesulfonyloxy or arenesulfonyloxy group which may have a substituent. The compound can be allowed to act to induce the compound represented by the general formula (I) or a salt thereof. Further, when R 2 of the compound represented by the general formula (XIII) or a salt thereof is alkylthio or arylthio which may have a substituent, the compound represented by the general formula (XIII) in which R 2 is the corresponding sulfoxy or sulfone The compound represented by the general formula (VIII) or a salt thereof can be converted to a compound represented by the general formula (I) or a salt thereof by reacting the compound represented by the general formula (VIII) or a salt thereof.

一般式(XIII)で表わされる化合物の塩としては、一般
式(I)および(II)で表わされる化合物で説明したと
同様の塩が挙げられる。
Examples of the salt of the compound represented by the general formula (XIII) include the same salts as those described for the compounds represented by the general formulas (I) and (II).

〔実施例〕〔Example〕

つぎに本発明を実施例および参考例を挙げて説明する
が、本発明はこれに限定されるものではない。
Next, the present invention will be described with reference to examples and reference examples, but the present invention is not limited thereto.

実施例1 2−(2,4−ジフルオロフエニルアミノ)−5−フルオ
ロ−6−ヒドロキシニコチン酸1.00gを無水テトラヒ
ドロフラン40mに懸濁させ、氷冷下でN,N′−カ
ルボニルジイミダゾール0.86gを添加し、室温で1.5
時間反応させる。ついで、エトキシカルボニル酢酸のマ
グネシウム塩1.60gを添加し、60℃で3時間反応さ
せた後、反応液を酢酸エチル80mおよび水80m
の混合液に加え、6N−塩酸でpH2.0に調整する。有機
層を分取し、飽和炭酸水素ナトリウム水溶液40mお
よび水40mで順次洗浄した後、水40mを加え、
6N−塩酸でpH2.0に調整する。有機層を分取し、水4
0mおよび飽和食塩水40mで順次洗浄した後、無
水硫酸マグネシウムで乾燥させる。減圧下に溶媒を留去
し、得られた結晶性物質にジエチルエーテル4mを加
えて結晶を取すれば、融点161〜162℃を示す2−〔2
−(2.4−ジフルオロフエニルアミノ)−5−フルオロ
−6−ヒドロキシニコチノイル〕酢酸エチルエステル0.
43g(収率34.5%)を得る。
Example 1 2.00 g of 2- (2,4-difluorophenylamino) -5-fluoro-6-hydroxynicotinic acid was suspended in 40 m of anhydrous tetrahydrofuran, and N, N'-carbonyldiimidazole was cooled under ice cooling. Add 0.86g, 1.5 at room temperature
React for hours. Then, 1.60 g of magnesium salt of ethoxycarbonylacetic acid was added and reacted at 60 ° C. for 3 hours, and then the reaction solution was mixed with 80 m of ethyl acetate and 80 m of water.
The pH of the mixture is adjusted to 2.0 with 6N hydrochloric acid. The organic layer was separated, washed successively with 40m saturated aqueous sodium hydrogen carbonate solution and 40m water, and then 40m water was added,
Adjust to pH 2.0 with 6N hydrochloric acid. Separate the organic layer and use water 4
The extract is washed successively with 0 m and saturated saline 40 m, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 4 m of diethyl ether was added to the obtained crystalline substance to collect crystals, which had a melting point of 161-162 ° C.
-(2.4-Difluorophenylamino) -5-fluoro-6-hydroxynicotinoyl] acetic acid ethyl ester 0.
43 g (yield 34.5%) are obtained.

IR(KBr)cm-1;νc=o 1725,1665 NMR(CDCl3)δ値; 1,29(3H,t,J=7Hz),3.74(2H,s),4.20(2H,q,J=7H
z),6.57〜7.69(4H,m),10.17(1H,bs),11,52(1H,b
s) 同様にしてつぎの化合物を得る。
IR (KBr) cm −1 ; ν c = o 1725,1665 NMR (CDCl 3 ) δ value; 1,29 (3H, t, J = 7Hz), 3.74 (2H, s), 4.20 (2H, q, J = 7H
z), 6.57 to 7.69 (4H, m), 10.17 (1H, bs), 11,52 (1H, b
s) Similarly, the following compound is obtained.

2−〔5−フルオロ−2−(4−フルオロフエニルア
ミノ)−6−ヒドロキシニコチノイル〕酢酸エチルエス
テル 融点;185℃(分解)(再結溶媒;酢酸エチル) IR(KBr)cm-1;νc=o 1715,1685 NMR(CDCl3)δ値; 1.30(3H,t,J=7Hz),3.75(2H,s),4.25(2H,q,J=7Hz),
7.08〜7.34(4H,m),7.48(1H,d,J=11Hz),11.68(1H,bs) 実施例2 6−クロロ−2−(2,4−ジフルオロフエニルアミノ)
−5−フルオロニコチン酸0.70gを無水テトラヒドロ
フラン30mに溶解させ、氷冷下でN,N′−カルボ
ニルジイミダゾール1.13gを添加し、室温で6時間反
応させる。ついで、エトキシカルボニル酢酸のマグネシ
ウム塩0.99gを添加し、55℃で2時間反応させた
後、反応液を酢酸エチル75mおよび水65mの混
合液に加え、6N−塩酸でpH2.0に調整する。有機層を
分取し、水30mを加え、飽和炭酸水素ナトリウム水
溶液でpH7.5に調整する。有機層を分取し、水30m
および飽和食塩水30mで順次洗浄した後、無水硫酸
マグネシウムで乾燥させる。減圧下に溶媒を留去し、得
られた残留物をカラムクロマトグラフイー〔和光シリカ
ゲルC−200、溶出溶媒;ベンゼン〕で精製すれば、
2−〔6−クロロ−2−(2,4−ジフルオロフエニルア
ミノ)−5−フルオロニコチノイル〕酢酸エチルエステ
ル0.68g(収率78.9%)を得る。これをジイソプロ
ピルエーテルで再結晶して融点92.5〜93℃を示す結
晶を得る。
2- [5-Fluoro-2- (4-fluorophenylamino) -6-hydroxynicotinoyl] acetic acid ethyl ester melting point; 185 ° C. (decomposition) (resolving solvent; ethyl acetate) IR (KBr) cm −1 ; ν c = o 1715,1685 NMR (CDCl 3 ) δ value; 1.30 (3H, t, J = 7Hz), 3.75 (2H, s), 4.25 (2H, q, J = 7Hz),
7.08 to 7.34 (4H, m), 7.48 (1H, d, J = 11Hz), 11.68 (1H, bs) Example 2 6-chloro-2- (2,4-difluorophenylamino)
0.70 g of -5-fluoronicotinic acid is dissolved in 30 m of anhydrous tetrahydrofuran, 1.13 g of N, N'-carbonyldiimidazole is added under ice cooling, and the mixture is reacted at room temperature for 6 hours. Then, 0.99 g of magnesium salt of ethoxycarbonylacetic acid was added and reacted at 55 ° C. for 2 hours, then the reaction solution was added to a mixed solution of 75 m of ethyl acetate and 65 m of water, and the pH was adjusted to 2.0 with 6N-hydrochloric acid. . The organic layer is separated, 30 m of water is added, and the pH is adjusted to 7.5 with a saturated aqueous sodium hydrogen carbonate solution. Separate the organic layer and water 30m
After successively washing with 30 m of saturated saline and drying with anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by column chromatography [Wako Silica Gel C-200, eluting solvent: benzene].
0.68 g (yield 78.9%) of 2- [6-chloro-2- (2,4-difluorophenylamino) -5-fluoronicotinoyl] acetic acid ethyl ester is obtained. This is recrystallized from diisopropyl ether to give crystals having a melting point of 92.5 to 93 ° C.

IR(KBr)cm-1;νc=o 1745 NMR(CDCl3)δ値; 1.31(3H,t,J=7Hz),3.97(2H,s),4.25(2H,q,J=7Hz),
6.65〜7.35(2H,m),7.85(1H,d,J=9Hz),8.00〜8.50(1
H,m),10.91(1H,bs) 同様にして、つぎの化合物を得る。
IR (KBr) cm −1 ; ν c = o 1745 NMR (CDCl 3 ) δ value; 1.31 (3H, t, J = 7Hz), 3.97 (2H, s), 4.25 (2H, q, J = 7Hz),
6.65 ~ 7.35 (2H, m), 7.85 (1H, d, J = 9Hz), 8.00 ~ 8.50 (1
H, m), 10.91 (1H, bs) Similarly, the following compound is obtained.

2−〔2−(2,4−ジフルオロフエニルアミノ)−5
−フルオロ−6−メトキシニコチノイル〕酢酸エチルエ
ステル 融点;149〜150℃(再結溶媒;ベンゼン) IR(KBr)cm-1;νc=o 1745 NMR(CDCl3)δ値; 1.30(3H,t,J=7Hz),3.90(2H,s),4.02(3H,s),4.27(2
H,q,J=7Hz),6.65〜7.35(2H,m),7.73(1H,d,J=10H
z),7.90〜8.40(1H,m),11.19(1H,bs) 2−〔2−(2,4−ジフルオロフエニルアミノ)−6
−エチルチオ−5−フルオロニコチノイル〕酢酸エチル
エステル 融点;102.5〜103℃(再結溶媒;ジイソプロピルエーテ
ル) IR(KBr)cm-1;νc=o 1730 NMR(CDCl3)δ値; 1.29(6H,t,J=7Hz),3.06(2H,q,J=7Hz),3.90(2H,s),
4.22(2H,q,J=7Hz),6.62〜7.35(2H,m),7.52(1H,d,J=
11Hz),7.70〜8.20(1H,m),10.86(1H,bs) 2−〔2−(2,4−ジフルオロフエニルアミノ)−5
−フルオロ−6−フエニルチオニコチノイル〕酢酸エチ
ルエステル 融点;132.5〜134℃(再結溶媒;酢酸エチル:n−ヘキ
サン=10:1) IR(KBr)cm-1;νc=o 1725 NMR(CDCl3)δ値; 1.27(3H,t,J=7Hz),3.89(2H,s),4.20(2H,q,J=7Hz),
5.98〜8.03(9H,m),11.12(1H,bs) 2−〔2−(2,4−ジフルオロフエニルアミノ)−5
−フルオロ−6−(2,4,6−トリメチルベンゼンスルホ
ニルオキシ)ニコチノイル〕酢酸〕エチルエステル 融点;160〜160.5℃(再結溶媒;ベンゼン) IR(KBr)cm-1;νc=o 1730 NMR(CDCl3)δ値; 1.27(3H,t,J=7Hz),2.32(3H,s),2.57(6H,s),3.90(2
H,s),4.20(2H,q,J=7Hz), 10.93(1H,bs) 2−〔6−(4−アセチル−1−ピペラジニル)−2
−(2,4−ジフルオロフエニルアミノ)−5−フルオロ
ニコチノイル〕酢酸エチルエステル 融点;160〜161℃(再結溶媒;ベンゼン) IR(KBr)cm-1;νc=o 1730,1640 NMR(CDCl3)δ値; 1.28(3H,t,J=7Hz),2.12(3H,s),3.38〜3.97(10H,m),
4.22(2H,q,J=7Hz),6.67〜7.20(2H,m),7.57(1H,d,J=
14Hz),7.77〜8.20(1H,m),10.98(1H,bs) 2−〔6−(3−アセチルアミノ−1−ピロリジニ
ル)−2−(2,4−ジフルオロフエニルアミノ)−5−
フルオロニコチノイル〕酢酸エチルエステル 融点;184〜185℃(再結溶媒;酢酸エチル:エタノール
=1:1) IR(KBr)cm-1;νc=o 1735,1670 NMR(CDCl3)δ値; 実施例3 (1)2−(2,4−ジフルオロフエニルアミノ)−5−フル
オロ−6−メトキシニコチン酸0.28gを塩化メチレン
3mに懸濁させ、室温で塩化チオニル0.58gおよび
N,N−ジメチルホルムアミド1滴を加え、加熱還流下
で2時間反応させる。減圧下に溶媒および過剰の塩化チ
オニルを留去し、得られた結晶性物質を塩化メチレン6
mに溶解させる。
2- [2- (2,4-difluorophenylamino) -5
-Fluoro-6-methoxynicotinoyl] acetic acid ethyl ester melting point; 149 to 150 ° C. (resolving solvent; benzene) IR (KBr) cm −1 ; ν c = o 1745 NMR (CDCl 3 ) δ value; 1.30 (3H, t, J = 7Hz), 3.90 (2H, s), 4.02 (3H, s), 4.27 (2
H, q, J = 7Hz), 6.65 to 7.35 (2H, m), 7.73 (1H, d, J = 10H
z), 7.90 to 8.40 (1H, m), 11.19 (1H, bs) 2- [2- (2,4-difluorophenylamino) -6
-Ethylthio-5-fluoronicotinoyl] acetic acid ethyl ester Melting point: 102.5 to 103 ° C (resolving solvent; diisopropyl ether) IR (KBr) cm -1 ; ν c = o 1730 NMR (CDCl 3 ) δ value; 1.29 (6H , t, J = 7Hz), 3.06 (2H, q, J = 7Hz), 3.90 (2H, s),
4.22 (2H, q, J = 7Hz), 6.62 to 7.35 (2H, m), 7.52 (1H, d, J =
11Hz), 7.70-8.20 (1H, m), 10.86 (1H, bs) 2- [2- (2,4-difluorophenylamino) -5
-Fluoro-6-phenylthionicotinoyl] acetic acid ethyl ester melting point; 132.5 to 134 ° C (resolving solvent; ethyl acetate: n-hexane = 10: 1) IR (KBr) cm −1 ; ν c = o 1725 NMR (CDCl 3 ) δ value; 1.27 (3H, t, J = 7Hz), 3.89 (2H, s), 4.20 (2H, q, J = 7Hz),
5.98 to 8.03 (9H, m), 11.12 (1H, bs) 2- [2- (2,4-difluorophenylamino) -5
-Fluoro-6- (2,4,6-trimethylbenzenesulfonyloxy) nicotinoyl] acetic acid] ethyl ester melting point; 160-160.5 ° C (resolving solvent; benzene) IR (KBr) cm -1 ; ν c = o 1730 NMR (CDCl 3 ) δ value; 1.27 (3H, t, J = 7Hz), 2.32 (3H, s), 2.57 (6H, s), 3.90 (2
H, s), 4.20 (2H, q, J = 7Hz), 10.93 (1H, bs) 2- [6- (4-acetyl-1-piperazinyl) -2
-(2,4-Difluorophenylamino) -5-fluoronicotinoyl] acetic acid ethyl ester melting point; 160 to 161 ° C (resolving solvent; benzene) IR (KBr) cm -1 ; ν c = o 1730,1640 NMR (CDCl 3 ) δ value; 1.28 (3H, t, J = 7Hz), 2.12 (3H, s), 3.38〜3.97 (10H, m),
4.22 (2H, q, J = 7Hz), 6.67 ~ 7.20 (2H, m), 7.57 (1H, d, J =
14Hz), 7.77-8.20 (1H, m), 10.98 (1H, bs) 2- [6- (3-acetylamino-1-pyrrolidinyl) -2- (2,4-difluorophenylamino) -5-
Fluoronicotinoyl] acetic acid ethyl ester Melting point: 184 to 185 ° C. (resolving solvent; ethyl acetate: ethanol = 1: 1) IR (KBr) cm −1 ; ν c = o 1735,1670 NMR (CDCl 3 ) δ value; Example 3 (1) 0.28 g of 2- (2,4-difluorophenylamino) -5-fluoro-6-methoxynicotinic acid was suspended in 3 m of methylene chloride, and 0.58 g of thionyl chloride and N, One drop of N-dimethylformamide is added, and the mixture is reacted under heating under reflux for 2 hours. The solvent and excess thionyl chloride were distilled off under reduced pressure, and the obtained crystalline substance was converted into methylene chloride 6
dissolve in m.

(2)ジフエニルメチル=エチル=マロナート0.59gを
無水テトラヒドロフラン6mに溶解させ、−20℃で水
素化ナトリウム(純度;50%)0.09gを添加し、0〜
10℃で1時間反応させる。ついで、反応液を−20℃に
冷却し、同温度で(1)で得られた塩化メチレン溶液を滴
下した後、−20〜−10℃で30分間反応させる。反応液
に酢酸0.12gを加え、減圧下に溶媒を留去し、得られ
た残留物に酢酸エチル20mおよび水10mを加
え、2N−塩酸でpH2.0に調整する。有機層を分取し、
水10mおよび飽和食塩水10mで順次洗浄した
後、無水硫酸マグネシウムで乾燥させる。減圧下に溶媒
を留去し、得られた残留物にジイソプロピルエーテル5
mを加え結晶を取すれば、ジフエニルメチル=エチ
ル=2−(2,4−ジフルオロフエニルアミノ)−5−フ
ルオロ−6−メトキシニコチノイルマロナート0.43g
(収率79.2%)を得る。これをベンゼン−n−ヘキサ
ン(容量比10:1)混合溶媒で再結晶して融点130〜131
℃を示す結晶を得る。
(2) 0.59 g of diphenylmethyl-ethyl-malonate was dissolved in 6 m of anhydrous tetrahydrofuran, and 0.09 g of sodium hydride (purity; 50%) was added at -20 ° C to give 0-
React at 10 ° C. for 1 hour. Then, the reaction solution is cooled to -20 ° C, the methylene chloride solution obtained in (1) is added dropwise at the same temperature, and the reaction is allowed to proceed at -20 to -10 ° C for 30 minutes. 0.12 g of acetic acid is added to the reaction solution, the solvent is distilled off under reduced pressure, 20 m of ethyl acetate and 10 m of water are added to the obtained residue, and the pH is adjusted to 2.0 with 2N-hydrochloric acid. Separate the organic layer,
After sequentially washing with 10 m of water and 10 m of saturated saline, it is dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and diisopropyl ether 5 was added to the obtained residue.
After adding m and collecting crystals, 0.43 g of diphenylmethyl = ethyl = 2- (2,4-difluorophenylamino) -5-fluoro-6-methoxynicotinoyl malonate
(Yield 79.2%) is obtained. This was recrystallized with a mixed solvent of benzene-n-hexane (volume ratio 10: 1) to give a melting point of 130-131.
Crystals showing ° C are obtained.

IR(KBr)cm-1;νc=o 1740,1730(sh) NMR(CDCl3)δ値; 1.24(3H,t,J=7Hz),3.94(3H,s),4.28(2H,q,J=7Hz),
5.14(1H,s),6.40〜7.64(14H,m),7.70〜8.20(1H,m),1
1.10(1H,bs) (3)ジフエニルメチル=エチル=2−(2,4−ジフルオロ
フエニルアミノ)−5−フルオロ−6−メトキシニコチ
ノイルマロナート0.20gをアニソール2mに溶解さ
せ、氷冷下でトリフルオロ酢酸2mを加え、同温度で
10分間反応させる。減圧下に溶媒を留去し、得られた
結晶性物質にジイソプロピルエーテル2mを加えて結
晶を取すれば、2−〔2−(2,4−ジフルオロフエニ
ルアミノ)−5−フルオロ−6−メトキシニコチノイ
ル〕酢酸エチルエステル0.12g(収率94.3%)を得
る。
IR (KBr) cm −1 ; ν c = o 1740,1730 (sh) NMR (CDCl 3 ) δ value; 1.24 (3H, t, J = 7Hz), 3.94 (3H, s), 4.28 (2H, q, J = 7Hz),
5.14 (1H, s), 6.40 ~ 7.64 (14H, m), 7.70 ~ 8.20 (1H, m), 1
1.10 (1H, bs) (3) Diphenylmethyl = ethyl = 2- (2,4-difluorophenylamino) -5-fluoro-6-methoxynicotinoyl malonate (0.20 g) was dissolved in anisole (2 m) and cooled with ice. Then, 2 m of trifluoroacetic acid is added, and the mixture is reacted at the same temperature for 10 minutes. The solvent was distilled off under reduced pressure, and 2 m of diisopropyl ether was added to the obtained crystalline substance to collect crystals. 2- [2- (2,4-difluorophenylamino) -5-fluoro-6- 0.12 g (yield 94.3%) of methoxynicotinoyl] acetic acid ethyl ester is obtained.

この化合物の物性は実施例2で得られたものと一致し
た。
The physical properties of this compound were the same as those obtained in Example 2.

実施例4 2−〔2−(2,4−ジフルオロフエニルアミノ)−5−
フルオロ−6−ヒドロキシニコチノイル〕酢酸エチルエ
ステル0.10gを酢酸エチル2mに溶解させ、氷冷下
でジアゾメタン0.015gを含むジエチルエーテル溶液
を添加した後、室温で30分間反応させる。ついで、反
応液に発泡が生じなくなるまで酢酸を加えた後、減圧下
に溶媒を留去する。得られた結晶性物質にジイソプロピ
ルエーテル2mを加えて結晶を取すれば、2−〔2
−(2,4−ジフルオロフエニルアミノ)−5−フルオロ
−6−メトキシニコチノイル〕酢酸エチルエステル0.0
8g(収率77.0%)を得る。
Example 4 2- [2- (2,4-difluorophenylamino) -5-
Fluoro-6-hydroxynicotinoyl] acetic acid ethyl ester (0.10 g) is dissolved in ethyl acetate (2 m), and a diethyl ether solution containing 0.015 g of diazomethane is added under ice-cooling, followed by reaction at room temperature for 30 minutes. Then, acetic acid is added until foaming does not occur in the reaction solution, and then the solvent is distilled off under reduced pressure. If 2 m of diisopropyl ether was added to the obtained crystalline substance to collect crystals, 2- [2
-(2,4-Difluorophenylamino) -5-fluoro-6-methoxynicotinoyl] acetic acid ethyl ester 0.0
8 g (yield 77.0%) are obtained.

この化合物の物性は実施例2で得られたものと一致し
た。
The physical properties of this compound were the same as those obtained in Example 2.

実施例5 2−〔2−2,4−ジフルオロフエニルアミノ)−5−フ
ルオロ−6−ヒドロキシニコチノイル〕酢酸エチルエス
テル0.40gを塩化メチレン4mに溶解させ、氷冷下
で2,4,6−トリメチルベンゼンスルホニルクロリド0.3
0gおよびトリエチルアミン0.15gを加え、室温で2
時間反応させる。ついで、反応液に塩化メチレン4m
および水4mを加え、有機層を分取し、水4mおよ
び飽和食塩水4mで順次洗浄した後、無水硫酸マグネ
シウムで乾燥させる。減圧下に溶媒を留去し、得られた
結晶性物質にジエチルエーテル2mを加えて結晶を
取すれば、2−〔2−(2,4−ジフルオロフエニルアミ
ノ)−5−フルオロ−6−(2,4,6−トリメチルベンゼ
ンスルホニルオキシ)ニコチノイル〕酢酸エチルエステ
ル0.52g(収率85.8%)を得る。
Example 5 0.40 g of 2- [2-2,4-difluorophenylamino) -5-fluoro-6-hydroxynicotinoyl] acetic acid ethyl ester was dissolved in 4 m of methylene chloride, and 2,4, 6-Trimethylbenzenesulfonyl chloride 0.3
0 g and triethylamine 0.15 g were added, and 2
React for hours. Then, add 4m of methylene chloride to the reaction mixture.
And 4 m of water are added, the organic layer is separated, washed successively with 4 m of water and 4 m of saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 2 m of diethyl ether was added to the obtained crystalline substance to collect crystals. 2- [2- (2,4-difluorophenylamino) -5-fluoro-6- 0.52 g (yield 85.8%) of (2,4,6-trimethylbenzenesulfonyloxy) nicotinoyl] acetic acid ethyl ester is obtained.

この化合物の物性は実施例2で得られたものと一致し
た。
The physical properties of this compound were the same as those obtained in Example 2.

同様にして、つぎの化合物を得る。Similarly, the following compound is obtained.

2−〔2−(2,4−ジフルオロフエニルアミノ)−5
−フルオロ−6−メタンスルホニルオキシニコチノイ
ル〕酢酸エチルエステル 融点;98〜99℃(再結溶媒;ベンゼン) IR(KBr)cm-1;νc=o 1730 NMR(CDCl3)δ値; 1.27(3H,t,J=7Hz),3.28(3H,s),3.93(2H,s),4.23(2
H,q,J=7Hz),6.63〜7.43(2H,m), 10.78(1H,bs) 実施例6 2−〔6−クロロ−2−(2,4−ジフルオロフエニルア
ミノ)−5−フルオロニコチノイル〕酢酸エチルエステ
ル0.15gをN,N−ジメチルホルムアミド1.5mに
溶解させ、チオフエノール0.07gおよびトリエチルア
ミン0.06gを添加し、室温で1時間反応させる。つい
で、反応液に酢酸エチル20mおよび水10mを加
え、2N−塩酸でpH2.0に調整する。有機層を分取し、
水10mおよび飽和食塩水10mで順次洗浄した
後、無水硫酸マグネシウムで乾燥させる。減圧下に溶媒
を留去し、得られた結晶性物質にn−ヘキサン5mを
加えて結晶を取すれば、2−〔2−(2,4−ジフルオ
ロフエニルアミノ)−5−フルオロ−6−フエニルチオ
ニコチノイル〕酢酸エチルエステル0.17g(収率94.
6%)を得る。
2- [2- (2,4-difluorophenylamino) -5
-Fluoro-6-methanesulfonyloxynicotinoyl] acetic acid ethyl ester melting point; 98 to 99 ° C. (resolving solvent; benzene) IR (KBr) cm −1 ; ν c = o 1730 NMR (CDCl 3 ) δ value; 1.27 ( 3H, t, J = 7Hz), 3.28 (3H, s), 3.93 (2H, s), 4.23 (2
H, q, J = 7Hz), 6.63 to 7.43 (2H, m), 10.78 (1H, bs) Example 6 2- [6-chloro-2- (2,4-difluorophenylamino) -5-fluoronicotinoyl] acetic acid ethyl ester 0.15 g was added to N, N-dimethylformamide 1. It is dissolved in 5 m, 0.07 g of thiophenol and 0.06 g of triethylamine are added, and the mixture is reacted at room temperature for 1 hour. Then, 20 m of ethyl acetate and 10 m of water are added to the reaction solution, and the pH is adjusted to 2.0 with 2N-hydrochloric acid. Separate the organic layer,
After sequentially washing with 10 m of water and 10 m of saturated saline, it is dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 5 m of n-hexane was added to the obtained crystalline substance to collect crystals. 2- [2- (2,4-difluorophenylamino) -5-fluoro-6 -Phenylthionicotinoyl] acetic acid ethyl ester 0.17 g (yield 94.
6%).

この化合物の物性は実施例2で得られたものと一致し
た。
The physical properties of this compound were the same as those obtained in Example 2.

実施例7 2−〔2−(2,4−ジフルオロフエニルアミノ)−5−
フルオロ−6−(2,4,6−トリメチルベンゼンスルホニ
ルオキシ)ニコチノイル〕酢酸エチルエステル0.10g
をN,N−ジメチルホルムアミド1mに溶解させ、エ
タンチオール0.017gおよびトリエチルアミン0.028gを
添加し、室温で4時間反応させる。ついで、反応液を酢
酸エチル3mおよび水3mの混合液に加え、2N−
塩酸でpH1.0に調整する。有機層を分取し、水2mお
よび飽和食塩水2mで順次洗浄した後、無水硫酸マグ
ネシウムで乾燥させる。減圧下に溶媒を留去し、得られ
た残留物をカラムクロマトグラフイー〔和光シリカゲル
C−200、溶出溶媒;ベンゼン:ヘキサン(容量比1:
2)〕で精製すれば、2−〔2−(2,4−ジフルオロフ
エニルアミノ)−6−エチルチオ−5−フルオロニコチ
ノイル〕酢酸エチルエステル0.05g(収率67.4%)
を得る。
Example 7 2- [2- (2,4-difluorophenylamino) -5-
Fluoro-6- (2,4,6-trimethylbenzenesulfonyloxy) nicotinoyl] acetic acid ethyl ester 0.10 g
Is dissolved in 1 m of N, N-dimethylformamide, 0.017 g of ethanethiol and 0.028 g of triethylamine are added, and the mixture is reacted at room temperature for 4 hours. Then, the reaction solution was added to a mixed solution of 3 m of ethyl acetate and 3 m of water, and 2N-
Adjust to pH 1.0 with hydrochloric acid. The organic layer is separated, washed successively with 2 m of water and 2 m of saturated saline and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was subjected to column chromatography [Wako Silica Gel C-200, eluting solvent; benzene: hexane (volume ratio 1:
2)], 2- [2- (2,4-difluorophenylamino) -6-ethylthio-5-fluoronicotinoyl] acetic acid ethyl ester 0.05 g (yield 67.4%)
To get

この化合物の物性は、実施例2で得られたものと一致し
た。
The physical properties of this compound were the same as those obtained in Example 2.

実施例8 2−〔6−クロロ−2−(2,4−ジフルオロフエニルア
ミノ)−5−フルオロニコチノイル〕酢酸エチルエステ
ル0.50gをクロロホルム5mに溶解させ、3−アミ
ノピロリジンの二塩酸塩0.26gおよびトリエチルアミ
ン0.50gを添加し、加熱還流下で1.5時間反応させ
る。ついで、反応液をクロロホルム5mおよび水5m
の混合液に加え、有機層を分取し、水5mおよび飽
和食塩水5mで順次洗浄した後、無水硫酸マグネシウ
ムで乾燥させる。減圧下に溶媒を留去し、得られた結晶
性物質にジイソプロピルエーテル2mを加えて結晶を
取すれば、融点140〜142℃を示す2−〔6−(3−ア
ミノ−1−ピロリジニル)−2−(2,4−ジフルオロフ
エニルアミノ)−5−フルオロニコチノイル〕酢酸エチ
ルエステル0.48g(収率84.7%)を得る。
Example 8 2- [6-chloro-2- (2,4-difluorophenylamino) -5-fluoronicotinoyl] acetic acid ethyl ester (0.50 g) was dissolved in chloroform (5 m) to give 3-aminopyrrolidine dihydrochloride. 0.26 g and triethylamine 0.50 g are added, and the mixture is reacted under heating under reflux for 1.5 hours. Then, the reaction solution was mixed with chloroform (5 m) and water (5 m).
The organic layer is separated, washed successively with 5 m of water and 5 m of saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 2 m of diisopropyl ether was added to the obtained crystalline substance to obtain crystals. 2- [6- (3-amino-1-pyrrolidinyl) -having a melting point of 140-142 ° C. 2- (2,4-Difluorophenylamino) -5-fluoronicotinoyl] acetic acid ethyl ester 0.48 g (yield 84.7%) is obtained.

IR(KBr)cm-1;νc=o 1730 NMR(DMSO-d6)δ値; 1.22(3H,t,J=7Hz),1.50〜2.30(2H,m),3.30〜4.40(9
H,m),6.80〜7.60(2H,m),7.81(1H,d,J=14Hz),8.00〜
8.70(1H,m),11.45(1H,bs) 実施例9 無水ピペラジン0.14gをエタノール1.5mに溶解さ
せ、2−〔6−クロロ−2−(2,4−ジフルオロフエニ
ルアミノ)−5−フルオロニコチノイル〕酢酸エチルエ
ステル0.15gを分割添加し、室温で30分間反応させ
る。ついで、反応液をクロロホルム5mおよび水5m
の混合液に加え、有機層を分取し、水3mおよび飽
和食塩水3mで順次洗浄した後、無水硫酸マグネシウ
ムで乾燥させる。減圧下に溶媒を留去し、得られた結晶
性物質にn−ヘキサン2mを加えて結晶を取すれ
ば、2−〔2−(2,4−ジフルオロフエニルアミノ)−
5−フルオロ−6−(1−ピペラジニル)ニコチノイ
ル〕酢酸エチルエステル0.07g(収率41.2%)を得
る。これを酢酸エチル−n−ヘキサン(容量比10:
1)混合溶媒で再結晶して融点121〜123℃を示す結晶を
得る。
IR (KBr) cm −1 ; ν c = o 1730 NMR (DMSO-d 6 ) δ value; 1.22 (3H, t, J = 7Hz), 1.50 to 2.30 (2H, m), 3.30 to 4.40 (9
H, m), 6.80 to 7.60 (2H, m), 7.81 (1H, d, J = 14Hz), 8.00 to
8.70 (1H, m), 11.45 (1H, bs) Example 9 0.14 g of anhydrous piperazine was dissolved in 1.5 m of ethanol to give 2- [6-chloro-2- (2,4-difluorophenylamino)- 5-Fluoronicotinoyl] acetic acid ethyl ester (0.15 g) is added portionwise, and the mixture is reacted at room temperature for 30 minutes. Then, the reaction solution was mixed with chloroform (5 m) and water (5 m).
The organic layer is separated, washed successively with 3 m of water and 3 m of saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 2 m of n-hexane was added to the obtained crystalline substance to collect crystals, and 2- [2- (2,4-difluorophenylamino)-
5-Fluoro-6- (1-piperazinyl) nicotinoyl] acetic acid ethyl ester 0.07 g (yield 41.2%) is obtained. Ethyl acetate-n-hexane (volume ratio 10:
1) Recrystallize with a mixed solvent to obtain crystals having a melting point of 121 to 123 ° C.

IR(KBr)cm-1;νc=o 1745,1730(sh) NMR(CDCl3)δ値; 1.30(3H,t,J=7Hz),2.76〜3.10(4H,m),3.55〜4.00(6
H,m),4.21(2H,q,J=7Hz),6.40〜7.20(2H,m),7.47(1
H,d,J=14Hz),7.75〜8.35(1H,m),11.10(1H,bs) 実施例10 3−アミノピロリジンの二塩酸塩0.05gをクロロホル
ム1.5mに懸濁させ、トリエチルアミン0.11gを加
え、室温で10分間反応させた後、2−〔2−(2,4−
ジフルオロフエニルアミノ)−5−フルオロ−6−(2,
4,6−トリメチルベンゼンスルホニルオキシ)ニコチノ
イル〕酢酸エチルエステル0.15gを加え、室温で1.5
時間反応させる。ついで、反応液にクロロホルム5m
および水5mを加え、有機層を分取し、水5mおよ
び飽和食塩水5mで順次洗浄した後、無水硫酸マグネ
シウムで乾燥させる。減圧下に溶媒を留去し、得られた
結晶性物質にジイソプロピルエーテル2mを加えて結
晶を取すれば、2−〔6−(3−アミノ−1−ピロリ
ジニル)−2−(2,4−ジフルオロフエニルアミノ)−
5−フルオロニコチノイル〕酢酸エチルエステル0.11
g(収率93.2%)を得る。
IR (KBr) cm −1 ; ν c = o 1745,1730 (sh) NMR (CDCl 3 ) δ value; 1.30 (3H, t, J = 7Hz), 2.76 to 3.10 (4H, m), 3.55 to 4.00 ( 6
H, m), 4.21 (2H, q, J = 7Hz), 6.40-7.20 (2H, m), 7.47 (1
H, d, J = 14 Hz), 7.75 to 8.35 (1H, m), 11.10 (1H, bs) Example 10 3-aminopyrrolidine dihydrochloride (0.05 g) was suspended in chloroform (1.5 m), and triethylamine (0) was added. After adding 0.11 g and reacting at room temperature for 10 minutes, 2- [2- (2,4-
Difluorophenylamino) -5-fluoro-6- (2,
4,6-Trimethylbenzenesulfonyloxy) nicotinoyl] acetic acid ethyl ester (0.15 g) was added, and the mixture was stirred at room temperature for 1.5.
React for hours. Then, add 5m of chloroform to the reaction mixture.
And 5 m of water are added, the organic layer is separated, washed successively with 5 m of water and 5 m of saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 2 m of diisopropyl ether was added to the obtained crystalline substance to collect crystals. 2- [6- (3-amino-1-pyrrolidinyl) -2- (2,4- Difluorophenylamino)-
5-Fluoronicotinoyl] acetic acid ethyl ester 0.11
g (yield 93.2%) are obtained.

この化合物の物性は実施例8で得られたものと一致し
た。
The physical properties of this compound were the same as those obtained in Example 8.

実施例11 無水ピペラジン0.13gを塩化メチレン2mに溶解さ
せ、氷冷下で2−〔2−(2,4−ジフルオロフエニルア
ミノ)−5−フルオロ−6−(2,4,6−トリメチルベン
ゼンスルホニルオキシ)ニコチノイル〕酢酸エチルエス
テル0.20gを添加し、同温度で40分間反応させる。
ついで、反応液を酢酸エチル10mおよび水10m
の混合液に加え、有機層を分取し、飽和炭酸水素ナトリ
ウム水溶液2mおよび飽和食塩水2mで順次洗浄し
た後、無水硫酸マグネシウムで乾燥させる。減圧下に溶
媒を留去し、得られた結晶性物質にn−ヘキサン1m
を加えて結晶を取すれば、2−〔2−(2,4−ジフル
オロフエニルアミノ)−5−フルオロ−6−(1−ピペ
ラジニル)ニコチノイル〕酢酸エチルエステル0.11g
(収率69.9%)を得る。
Example 11 0.13 g of anhydrous piperazine was dissolved in 2 m of methylene chloride, and 2- [2- (2,4-difluorophenylamino) -5-fluoro-6- (2,4,6-trimethyl was dissolved under ice cooling. Benzenesulfonyloxy) nicotinoyl] acetic acid ethyl ester (0.20 g) is added, and the mixture is reacted at the same temperature for 40 minutes.
Then, the reaction solution was mixed with 10 m of ethyl acetate and 10 m of water.
The organic layer is separated, washed successively with 2 m of a saturated aqueous sodium hydrogen carbonate solution and 2 m of a saturated saline solution, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 1 m of n-hexane was added to the obtained crystalline substance.
Then, the crystals are added to give 2- [2- (2,4-difluorophenylamino) -5-fluoro-6- (1-piperazinyl) nicotinoyl] acetic acid ethyl ester 0.11 g.
(Yield 69.9%) is obtained.

この化合物の物性は実施例9で得られたものと一致し
た。
The physical properties of this compound were the same as those obtained in Example 9.

実施例12 2−〔6−(3−アミノ−1−ピロリジニル)−2−
(2,4−ジフルオロフエニルアミノ)−5−フルオロニ
コチノイル〕酢酸エチルエステル0.10gをクロロホル
ム1mに溶解させ、無水酢酸0.026gを滴下し、室温
で30分間反応させる。ついで、反応液を水1mおよ
びクロロホルム1mの混合液に加え、有機層を分取
し、水1mおよび飽和食塩水1mで順次洗浄した
後、無水硫酸マグネシウムで乾燥させる。減圧下に溶媒
を留去し、得られた結晶性物質にジイソプロピルエーテ
ル0.5mを加えて結晶を取すれば、2−〔6−(3
−アセチルアミノ−1−ピロリジニル)−2−(2,4−
ジフルオロフエニルアミノ)−5−フルオロニコチノイ
ル〕酢酸エチルエステル0.08g(収率72.8%)を得
る。
Example 12 2- [6- (3-amino-1-pyrrolidinyl) -2-
0.10 g of (2,4-difluorophenylamino) -5-fluoronicotinoyl] acetic acid ethyl ester is dissolved in 1 m of chloroform, 0.026 g of acetic anhydride is added dropwise, and the mixture is reacted at room temperature for 30 minutes. Then, the reaction solution is added to a mixed solution of 1 m of water and 1 m of chloroform, the organic layer is separated, washed successively with 1 m of water and 1 m of saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 0.5 m of diisopropyl ether was added to the obtained crystalline substance to collect crystals, and 2- [6- (3
-Acetylamino-1-pyrrolidinyl) -2- (2,4-
Difluorophenylamino) -5-fluoronicotinoyl] acetic acid ethyl ester 0.08 g (yield 72.8%) is obtained.

この化合物の物性は、実施例2で得られたものと一致し
た。
The physical properties of this compound were the same as those obtained in Example 2.

同様にして、つぎの化合物を得る。Similarly, the following compound is obtained.

2−〔6−(4−アセチル−1−ピペラジニル)−2
−(2,4−ジフルオロフエニルアミノ)−5−フルオロ
ニコチノイル〕酢酸エチルエステル この化合物の物性は実施例2で得られたものと一致し
た。
2- [6- (4-acetyl-1-piperazinyl) -2
-(2,4-Difluorophenylamino) -5-fluoronicotinoyl] acetic acid ethyl ester The physical properties of this compound were the same as those obtained in Example 2.

参考例1 (1)β−イミノ−β−フエノキシプロピオン酸エチルエ
ステルの塩酸塩50gおよび2,4−ジフルオロアニリン
27.8gを酢酸エチル300mに懸濁させ、加熱還流
下で2時間反応させる。析出結晶を取し、酢酸エチル
200mで2回洗浄すれば、融点196〜197℃を示すN
−(2,4−ジフルオロフエニル)アミジノ酢酸エチルエ
ステルの塩酸塩47g(収率82.2%)を得る。
Reference Example 1 (1) 50 g of β-imino-β-phenoxypropionic acid ethyl ester hydrochloride and 27.8 g of 2,4-difluoroaniline were suspended in 300 m of ethyl acetate and reacted under heating under reflux for 2 hours. . If the precipitated crystals are collected and washed twice with 200 m of ethyl acetate, N having a melting point of 196 to 197 ° C is obtained.
47 g (yield 82.2%) of the hydrochloride of-(2,4-difluorophenyl) amidinoacetic acid ethyl ester are obtained.

IR(KBr)cm-1;νc=o 1730 NMR(DMSO-d6)δ値; 1.26(3H,t,J=7Hz),4.07(2H,s),4.19(2H,q,J=7Hz),
7.02〜7.78(3H,m),9.11(1H,bs),10.26(1H,bs),12.28
(1H,bs) 同様にして、つぎの化合物を得る。
IR (KBr) cm −1 ; ν c = o 1730 NMR (DMSO-d 6 ) δ value; 1.26 (3H, t, J = 7Hz), 4.07 (2H, s), 4.19 (2H, q, J = 7Hz ) 、
7.02 ~ 7.78 (3H, m), 9.11 (1H, bs), 10.26 (1H, bs), 12.28
(1H, bs) Similarly, the following compound is obtained.

N−(2,4−ジフルオロフエニル)アミジノ酢酸メチ
ルエステルの塩酸塩 融点;192〜193℃ IR(KBr)cm-1;νc=o 1735 NMR(DMSO-d6)δ値; 3.74(3H,s),4.09(2H,s),6.91〜7.73(3H,m),9.15(1H,
bs),10.31(1H,bs),12.29(1H,bs) N−(4−フルオロフエニル)アミジノ酢酸メチルエ
ステルの塩酸塩 融点;134〜135℃ IR(KBr)cm-1;νc=o 1730 NMR(DMSO-d6)δ値; 3.74(3H,s),4.05(2H,s),7.01〜7.59(4H,m),8.96(1H,
bs),10.06(1H,bs),12.26(1H,bs) (2)N−(2,4−ジフルオロフエニル)アミジノ酢酸メチ
ルエステルの塩酸塩23.0gを水92mおよび塩化メ
チレン92mの混合液に溶解させ、2N−水酸化ナト
リウム水溶液でpH13.0に調整する。ついで、有機層を分
取し、水50mおよび飽和食塩水50mで順次洗浄
し、無水硫酸マグネシウムで乾燥させる。この溶液にα
−ホルミル−α−フルオロ酢酸エチルエステルのナトリ
ウム塩27.1gを室温で加え、加熱還流下で4時間反応
させた後、減圧下に溶媒を留去する。得られた残留物に
水92mおよび酢酸エチル46mを加え、析出結晶
を取する。ついで、得られた結晶を水184mに懸
濁させ、6N−塩酸でpH1.0に調整した後、析出結晶に
水46mおよび2−プロパノール46mを加えて結
晶を取すれば、2−(2,4−ジフルオロフエニルアミ
ノ)−5−フルオロ−6−ヒドロキシニコチン酸メチル
エステル15.0g(収率57.9%)を得る。これを酢酸
エチルで再結晶して融点222〜223℃を示す結晶を得る。
Hydrochloride of N- (2,4-difluorophenyl) amidinoacetic acid methyl ester Melting point; 192-193 ° C IR (KBr) cm -1 ; ν c = o 1735 NMR (DMSO-d 6 ) δ value; 3.74 (3H , s), 4.09 (2H, s), 6.91 to 7.73 (3H, m), 9.15 (1H,
bs), 10.31 (1H, bs), 12.29 (1H, bs) N- (4-Fluorophenyl) amidinoacetic acid methyl ester hydrochloride Melting point; 134-135 ° C IR (KBr) cm -1 ; ν c = o 1730 NMR (DMSO-d 6 ) δ value; 3.74 (3H, s), 4.05 (2H, s), 7.01 to 7.59 (4H, m), 8.96 (1H,
bs), 10.06 (1H, bs), 12.26 (1H, bs) (2) N- (2,4-difluorophenyl) amidinoacetic acid methyl ester hydrochloride 23.0 g was mixed with water 92 m and methylene chloride 92 m. And is adjusted to pH 13.0 with a 2N sodium hydroxide aqueous solution. Then, the organic layer is separated, washed successively with 50 m of water and 50 m of saturated saline and dried over anhydrous magnesium sulfate. Α in this solution
27.1 g of sodium salt of formyl-α-fluoroacetic acid ethyl ester is added at room temperature, and the mixture is reacted under heating under reflux for 4 hours, and then the solvent is distilled off under reduced pressure. Water (92 m) and ethyl acetate (46 m) are added to the obtained residue, and the precipitated crystals are collected. Then, the obtained crystals were suspended in 184 m of water and adjusted to pH 1.0 with 6N-hydrochloric acid, and then 46 m of water and 46 m of 2-propanol were added to the precipitated crystals to collect the crystals. 4-difluorophenylamino) -5-fluoro-6-hydroxynicotinic acid methyl ester 15.0 g (yield 57.9%) is obtained. This is recrystallized from ethyl acetate to give crystals having a melting point of 222-223 ° C.

IR(KBr)cm-1;νc=o 1700 NMR(TFA-d1)δ値; 4.06(3H,s),6.71〜7.65(3H,m),8.12(1H,d,J=11Hz) 同様にして、つぎの化合物を得る。IR (KBr) cm −1 ; ν c = o 1700 NMR (TFA-d 1 ) δ value; 4.06 (3H, s), 6.71 to 7.65 (3H, m), 8.12 (1H, d, J = 11Hz) Then, the following compound is obtained.

5−フルオロ−2−(4−フルオロフエニルアミノ)
−6−ヒドロキシニコチン酸メチルエステル 融点;227〜228℃(再結溶媒;酢酸エチル) IR(KBr)cm-1;νc=o 1690 NMR(TFA-d1)δ値; 4.05(3H,s),6.89〜7.53(4H,m),8.11(1H,d,J=11Hz) 参考例2 2−(2,4−ジフルオロフエニルアミノ)−5−フルオ
ロ−6−ヒドロキシニコチン酸メチルエステル0.20g
をテトラヒドロフラン6mに溶解させ、氷冷下でジア
ゾメタン0.04gを含むジエチルエーテル溶液を添加し
た後、室温で30分間反応させる。ついで、反応液に発
泡が生じなくなるまで酢酸を加えた後、減圧下に溶媒を
留去する。得られた結晶性物質に2−プロパノール6m
を加えて結晶を取すれば、2−(2,4−ジフルオロ
フエニルアミノ)−5−フルオロ−6−メトキシニコチ
ン酸メチルエステル0.15g(収率71.6%)を得る。
これを酢酸エチルで再結晶して融点160.5〜161.5℃を示
す結晶を得る。
5-fluoro-2- (4-fluorophenylamino)
-6-Hydroxynicotinic acid methyl ester melting point; 227-228 ° C (resolving solvent; ethyl acetate) IR (KBr) cm -1 ; ν c = o 1690 NMR (TFA-d 1 ) δ value; 4.05 (3H, s ), 6.89 to 7.53 (4H, m), 8.11 (1H, d, J = 11Hz) Reference Example 2 2- (2,4-difluorophenylamino) -5-fluoro-6-hydroxynicotinic acid methyl ester 0. 20 g
Is dissolved in 6 m of tetrahydrofuran, a diethyl ether solution containing 0.04 g of diazomethane is added under ice cooling, and the mixture is reacted at room temperature for 30 minutes. Then, acetic acid is added until foaming does not occur in the reaction solution, and then the solvent is distilled off under reduced pressure. 2-propanol 6m to the obtained crystalline substance
Is added and the crystals are collected to obtain 0.15 g of 2- (2,4-difluorophenylamino) -5-fluoro-6-methoxynicotinic acid methyl ester (yield 71.6%).
This is recrystallized from ethyl acetate to obtain crystals having a melting point of 160.5 to 161.5 ° C.

IR(KBr)cm-1;νc=o 1690 NMR(CDCl3)δ値; 3.89(3H,s),3.98(3H,s),6.57〜7.08(2H,m),7.81(1H,
d,J=11Hz),8.10〜8.97(1H,m),10.24(1H,bs) 参考例3 2−(2,4−ジフルオロフエニルアミノ)−5−フルオ
ロ−6−ヒドロキシニコチン酸メチルエステル9.5g、
五塩化リン26.5gおよびオキシ塩化リン46.9gの混
合物を70〜80℃で4時間反応させる。ついで、反応
液を水285mに徐々に加え、析出する結晶を取し
た後、水57mで洗浄する。得られた結晶をカラムク
ロマトグラフイー〔和光シリカゲルC−200,溶出溶
媒;トルエン〕で精製すれば、6−クロロ−2−(2,4
−ジフルオロフエニルアミノ)−5−フルオロニコチン
酸メチルエステル3.5g(収率34.7%)を得る。これ
をジイソプロピルエーテルで再結晶して融点139.5〜14
0.5℃を示す結晶を得る。
IR (KBr) cm −1 ; ν c = o 1690 NMR (CDCl 3 ) δ value; 3.89 (3H, s), 3.98 (3H, s), 6.57 to 7.08 (2H, m), 7.81 (1H,
d, J = 11 Hz), 8.10 to 8.97 (1H, m), 10.24 (1H, bs) Reference Example 3 2- (2,4-difluorophenylamino) -5-fluoro-6-hydroxynicotinic acid methyl ester 9 .5g,
A mixture of 26.5 g of phosphorus pentachloride and 46.9 g of phosphorus oxychloride is reacted at 70-80 ° C for 4 hours. Then, the reaction solution is gradually added to 285 m of water, the precipitated crystals are collected, and then washed with 57 m of water. The obtained crystals were purified by column chromatography [Wako Silica Gel C-200, eluting solvent: toluene] to give 6-chloro-2- (2,4
3.5 g (yield 34.7%) of methyl difluorophenylamino) -5-fluoronicotinate are obtained. This was recrystallized from diisopropyl ether to give a melting point of 139.5-14.
Crystals showing 0.5 ° C. are obtained.

IR(KBr)cm-1;νc=o 1695 NMR(CDCl3)δ値; 3.93(3H,s),6.61〜7.06(2H,m),7.94(1H,d,J=9Hz),
8.15〜8.57(1H,m),10.13(1H,bs) 参考例4 2−(2,4−ジフルオロフエニルアミノ)−5−フルオ
ロ−6−ヒドロキシニコチン酸メチルエステル0.50g
を塩化メチレン10mに懸濁させ、2,4,6−トリメチ
ルベンゼンスルホニルクロリド0.44gおよびトリエチ
ルアミン0.22gを加え、室温で3時間反応させる。こ
の溶液に水15mを加え、有機層を分取し、水15m
で洗浄した後、無水硫酸マグネシウムで乾燥させる。
減圧下に溶媒を留去し、得られた結晶性物質にジエチル
エーテル15mを加えて結晶を取すれば、2−(2,
4−ジフルオロフエニルアミノ)−5−フルオロ−6−
(2,4,6−トリメチルベンゼンスルホニルオキシ)ニコ
チン酸メチルエステル0.66g(収率81.9%)を得
る。これを酢酸エチルで再結晶して融点155〜156℃を示
す結晶を得る。
IR (KBr) cm −1 ; ν c = o 1695 NMR (CDCl 3 ) δ value; 3.93 (3H, s), 6.61 to 7.06 (2H, m), 7.94 (1H, d, J = 9Hz),
8.15-8.57 (1H, m), 10.13 (1H, bs) Reference Example 4 2- (2,4-Difluorophenylamino) -5-fluoro-6-hydroxynicotinic acid methyl ester 0.50 g
Is suspended in 10 m of methylene chloride, 0.44 g of 2,4,6-trimethylbenzenesulfonyl chloride and 0.22 g of triethylamine are added, and the mixture is reacted at room temperature for 3 hours. Water 15m was added to this solution, the organic layer was separated, and water 15m
After washing with, dried over anhydrous magnesium sulfate.
The solvent was distilled off under reduced pressure, 15 m of diethyl ether was added to the obtained crystalline substance to collect crystals, and 2- (2,
4-difluorophenylamino) -5-fluoro-6-
0.66 g (yield 81.9%) of (2,4,6-trimethylbenzenesulfonyloxy) nicotinic acid methyl ester is obtained. This is recrystallized from ethyl acetate to obtain crystals having a melting point of 155-156 ° C.

IR(KBr)cm-1;νc=o 1700 NMR(CDCl3)δ値; 2.33(3H,s),2.59(6H,s),3.92(3H,s),6.32〜6.84(2H,
m),6.92(2H,s),7.35〜7.94(1H,m),8.05(1H,d,J=9H
z),10.17(1H,bs) 参考例5 6−クロロ−2−(2,4−ジフルオロフエニルアミノ)
−5−フルオロニコチン酸メチルエステル0.70gを
N,N−ジメチルホルムアミド7mに懸濁させ、室温
でトリエチルアミン0.34gおよびエタンチオール0.2
1gを添加し、50℃で4時間反応させる。ついで、反
応液に酢酸エチル40mおよび水30mを加え、2
N−塩酸でpH2.0に調整する。有機層を分取し、水20
mおよび飽和食塩水20mで順次洗浄した後、無水
硫酸マグネシウムで乾燥させる。減圧下に溶媒を留去
し、得られた結晶性物質にn−ヘキサン10mを加え
て結晶を取すれば、6−エチルチオ−2−(2,4−ジ
フルオロフエニルアミノ)−5−フルオロニコチン酸メ
チルエステル0.62g(収率81.9%)を得る。これを
ジイソプロピルエーテルで再結晶して融点113.5〜114℃
を示す結晶を得る。
IR (KBr) cm −1 ; ν c = o 1700 NMR (CDCl 3 ) δ value; 2.33 (3H, s), 2.59 (6H, s), 3.92 (3H, s), 6.32 to 6.84 (2H,
m), 6.92 (2H, s), 7.35 to 7.94 (1H, m), 8.05 (1H, d, J = 9H
z), 10.17 (1H, bs) Reference Example 5 6-chloro-2- (2,4-difluorophenylamino)
0.70 g of -5-fluoronicotinic acid methyl ester was suspended in 7 m of N, N-dimethylformamide, and 0.34 g of triethylamine and 0.2 of ethanethiol were added at room temperature.
1 g is added and reacted at 50 ° C. for 4 hours. Then, 40 m of ethyl acetate and 30 m of water were added to the reaction solution, and 2
Adjust to pH 2.0 with N-hydrochloric acid. Separate the organic layer and add water 20
m and saturated saline solution (20 m), and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 10 m of n-hexane was added to the obtained crystalline substance to collect crystals. 6-ethylthio-2- (2,4-difluorophenylamino) -5-fluoronicotine 0.62 g (yield 81.9%) of acid methyl ester is obtained. This is recrystallized from diisopropyl ether and the melting point is 113.5 to 114 ° C
To obtain crystals.

IR(KBr)cm-1;νc=o 1680 NMR(CDCl3)δ値; 1.29(3H,t,J=7Hz),3.07(2H,q,J=7Hz),3.90(3H,s),
6.50〜7.20(2H,m),7.66(1H,d,J=10Hz),7.80〜8.50(1
H,m),10.00(1H,s) 同様にして、つぎの化合物を得る。
IR (KBr) cm −1 ; ν c = o 1680 NMR (CDCl 3 ) δ value; 1.29 (3H, t, J = 7Hz), 3.07 (2H, q, J = 7Hz), 3.90 (3H, s),
6.50 to 7.20 (2H, m), 7.66 (1H, d, J = 10Hz), 7.80 to 8.50 (1
H, m), 10.00 (1H, s) Similarly, the following compound is obtained.

2−(2,4−ジフルオロフエニルアミノ)−5−フル
オロ−6−フエニルチオニコチン酸メチルエステル 融点;128〜128.5℃(再結溶媒;ジイソプロピルエーテ
ル) IR(KBr)cm-1;νc=o 1685 NMR(CDCl3)δ値; 3.90(3H,s), 10.25(1H,bs) 参考例6 3−アミノピロリジンの二塩酸塩0.12gをN,N−ジ
メチルホルムアミド3mに懸濁させ、トリエチルアミ
ン0.25gを加え、室温で5分間反応させた後、2−
(2,4−ジフルオロフエニルアミノ)−5−フルオロ−
6−(2,4,6−トリメチルベンゼンスルホニルオキシ)
ニコチン酸メチルエステル0.30gを加え、室温で1.5
時間反応させる。反応液にクロロホルム10mおよび
水10mを加え、有機層を分取し、水10mおよび
飽和食塩水10mで順次洗浄した後、無水硫酸マグネ
シウムで乾燥させる。ついで無水酢酸0.10gを加え、
室温で10分間反応させた後、減圧下に溶媒を留去す
る。得られた結晶性物質にジエチルエーテル5mを加
え結晶を取すれば、6−(3−アセチルアミノ−1−
ピロリジニル)−2−(2,4−ジフルオロフエニルアミ
ノ)−5−フルオロニコチン酸メチルエステル0.21g
(収率82.4%)を得る。これを酢酸エチルで再結晶し
て融点202〜203℃を示す結晶を得る。
2- (2,4-Difluorophenylamino) -5-fluoro-6-phenylthionicotinic acid methyl ester Melting point; 128-128.5 ° C (resolving solvent; diisopropyl ether) IR (KBr) cm -1 ; ν c = O 1685 NMR (CDCl 3 ) δ value; 3.90 (3H, s), 10.25 (1H, bs) Reference Example 6 0.12 g of 3-aminopyrrolidine dihydrochloride was suspended in 3 m of N, N-dimethylformamide, 0.25 g of triethylamine was added, and the mixture was reacted at room temperature for 5 minutes, and then 2 −
(2,4-difluorophenylamino) -5-fluoro-
6- (2,4,6-trimethylbenzenesulfonyloxy)
Add 0.30 g of nicotinic acid methyl ester and add 1.5 at room temperature.
React for hours. Chloroform (10 m) and water (10 m) were added to the reaction solution, the organic layer was separated, washed successively with water (10 m) and saturated brine (10 m), and dried over anhydrous magnesium sulfate. Then add 0.10 g of acetic anhydride,
After reacting for 10 minutes at room temperature, the solvent is distilled off under reduced pressure. 5 m of diethyl ether was added to the obtained crystalline substance to collect crystals, and 6- (3-acetylamino-1-
Pyrrolidinyl) -2- (2,4-difluorophenylamino) -5-fluoronicotinic acid methyl ester 0.21 g
(Yield 82.4%) is obtained. This is recrystallized from ethyl acetate to give crystals having a melting point of 202-203 ° C.

IR(KBr)cm-1;νc=o 1675 NMR(CDCl3-DMSO-d6)δ値; 6.63〜7.17(2H,m),7.62(1H,d,J=14Hz),7.83〜8.60(2
H,m),10.30(1H,bs) 同様にして、つぎの化合物を得る。
IR (KBr) cm -1 ; ν c = o 1675 NMR (CDCl 3 -DMSO-d 6 ) δ value; 6.63 to 7.17 (2H, m), 7.62 (1H, d, J = 14Hz), 7.83 to 8.60 (2
H, m), 10.30 (1H, bs) Similarly, the following compound is obtained.

6−(4−アセチル−1−ピペラジニル)−2−(2,
4−ジフルオロフエニルアミノ)−5−フルオロニコチ
ン酸メチルエステル 融点;172〜173℃(再結溶媒;酢酸エチル) IR(KBr)cm-1;νc=o 1680,1650 NMR(CDCl3)δ値; 2.13(3H,s), 6.57〜7.07(2H,m),7.68(1H,d,J=13Hz),7.77〜8.18(1
H,m),10.05(1H,bs) 参考例7 2−(2,4−ジフルオロフエニルアミノ)−5−フルオ
ロ−6−ヒドロキシニコチン酸メチルエステル3.00g
をメタノール30mに懸濁させ、室温で2N−水酸化
ナトリウム水溶液16.1mを加えた後、加熱還流下で
4時間反応させる。ついで、反応液を酢酸エチル60m
および水60mの混合液に加え、水層を分取する。
この水層を6N−塩酸でpH1.0に調整し、析出晶を取
した後、水15mおよび2−プロパノール15mで
順次洗浄すれば、2−(2,4−ジフルオロフエニルアミ
ノ)−5−フルオロ−6−ヒドロキシニコチン酸2.68
g(収率93.7%)を得る。これをアセトン−エタノー
ル(容量比1:1)混合溶媒で再結晶して融点215〜215
℃を示す結晶を得る。
6- (4-acetyl-1-piperazinyl) -2- (2,
4-difluorophenylamino) -5-fluoronicotinic acid methyl ester melting point; 172-173 ° C (resolving solvent; ethyl acetate) IR (KBr) cm -1 ; ν c = o 1680,1650 NMR (CDCl 3 ) δ Value; 2.13 (3H, s), 6.57 to 7.07 (2H, m), 7.68 (1H, d, J = 13Hz), 7.77 to 8.18 (1
H, m), 10.05 (1H, bs) Reference Example 7 2- (2,4-Difluorophenylamino) -5-fluoro-6-hydroxynicotinic acid methyl ester 3.00 g
Is suspended in 30 m of methanol, 16.1 m of 2N-sodium hydroxide aqueous solution is added at room temperature, and the mixture is reacted under heating under reflux for 4 hours. Then, the reaction solution was mixed with 60 m of ethyl acetate.
And 60 m of water are added to the mixture, and the aqueous layer is separated.
This aqueous layer was adjusted to pH 1.0 with 6N-hydrochloric acid, and the precipitated crystals were collected and washed successively with 15 m of water and 15 m of 2-propanol to give 2- (2,4-difluorophenylamino) -5- Fluoro-6-hydroxynicotinic acid 2.68
g (yield 93.7%) are obtained. This was recrystallized from a mixed solvent of acetone-ethanol (volume ratio 1: 1) to give a melting point of 215-215.
Crystals showing ° C are obtained.

IR(KBr)cm-1;νc=o 1700 NMR(DMSO-d6)δ値; 6.65〜7.58(2H,m),7.86(1H,d,J=11Hz),8.12〜8.68(1
H,m),10.49(1H,bs) 同様にして、つぎの化合物を得る。
IR (KBr) cm −1 ; ν c = o 1700 NMR (DMSO-d 6 ) δ value; 6.65 to 7.58 (2H, m), 7.86 (1H, d, J = 11Hz), 8.12 to 8.68 (1
H, m), 10.49 (1H, bs) Similarly, the following compound is obtained.

5−フルオロ−2−(4−フルオロフエニルアミノ)
−6−ヒドロキシニコチン酸 融点;216〜217℃(再結溶媒;アセトン:メタノール=
1:1) IR(KBr)cm-1;νc=o 1685(sh) NMR(DMSO-d6)δ値; 6.84〜7.94(5H,m),10.33(1H,bs) 参考例8 2−(2,4−ジフルオロフエニルアミノ)−5−フルオ
ロ−6−メトキシニコチン酸メチルエステル2.00gを
テトラヒドロフラン60mに溶解させ、室温で1N−
水酸化ナトリウム水溶液25.5mを加え、加熱還流下
で7時間反応させる。ついで、減圧下に溶媒を留去し、
得られた残留物に酢酸エチル100mおよび水100
mを加え、2N−塩酸でpH2.0に調整する。有機層を
分取し、水50mおよび飽和食塩水50mで順次洗
浄した後、無水硫酸マグネシウムで乾燥させる。減圧下
に溶媒を留去し、得られた結晶性物質にジエチルエーテ
ル10mを加えて結晶を取すれば、2−(2,4−ジ
フルオロフエニルアミノ)−5−フルオロ−6−メトキ
シニコチン酸1.40g(収率73.3%)を得る。これを
アセトンで再結晶して融点239〜240℃を示す結晶を得
る。
5-fluoro-2- (4-fluorophenylamino)
-6-Hydroxynicotinic acid Melting point; 216 to 217 ° C (resolving solvent; acetone: methanol =
1: 1) IR (KBr) cm −1 ; ν c = o 1685 (sh) NMR (DMSO-d 6 ) δ value; 6.84 to 7.94 (5H, m), 10.33 (1H, bs) Reference Example 8 2- (2,4-Difluorophenylamino) -5-fluoro-6-methoxynicotinic acid methyl ester 2.00 g was dissolved in 60 m of tetrahydrofuran, and 1N-at room temperature.
25.5 m of sodium hydroxide aqueous solution is added, and the mixture is reacted under heating under reflux for 7 hours. Then, the solvent was distilled off under reduced pressure,
100 m of ethyl acetate and 100 ml of water were added to the obtained residue.
m is added and the pH is adjusted to 2.0 with 2N hydrochloric acid. The organic layer is separated, washed successively with 50 m of water and 50 m of saturated saline, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 10 m of diethyl ether was added to the obtained crystalline substance to collect crystals. 2- (2,4-difluorophenylamino) -5-fluoro-6-methoxynicotinic acid 1.40 g (yield 73.3%) are obtained. This is recrystallized with acetone to obtain crystals having a melting point of 239 to 240 ° C.

IR(KBr)cm-1;νc=o 1665 NMR(DMSO-d6)δ値; 3.98(3H,s),6.76〜7.48(2H,m),7.86(1H,d,J=11Hz),
8.10〜8.60(1H,m),10.51(1H,bs) 同様にして、つぎの化合物を得る。
IR (KBr) cm −1 ; ν c = o 1665 NMR (DMSO-d 6 ) δ value; 3.98 (3H, s), 6.76 to 7.48 (2H, m), 7.86 (1H, d, J = 11Hz),
8.10 to 8.60 (1H, m), 10.51 (1H, bs) Similarly, the following compound is obtained.

6−クロロ−2−(2,4−ジフルオロフエニルアミ
ノ)−5−フルオロニコチン酸 融点;226〜228℃(再結溶媒;ベンゼン) IR(KBr)cm-1;νc=o 1680 NMR(アセトン-d6)δ値; 6.60〜7.41(2H,m), 10.30(1H,bs),10.64(1H,bs) 2−(2,4−ジフルオロフエニルアミノ)−5−フル
オロ−6−(2,4,6−トリメチルベンゼンスルホニルオ
キシ)ニコチン酸 融点;179〜180℃(再結溶媒;ベンゼン) IR(KBr)cm-1;νc=o 1665 NMR(アセトン-d6)δ値; 2.32(3H,s),2.55(6H,s), 2−(2,4−ジフルオロフエニルアミノ)−6−エチ
ルチオ−5−フルオロニコチン酸 融点;209〜210℃(再結溶媒;ベンゼン) IR(KBr)cm-1;νc=o 1665 NMR(アセトン−d6)δ値; 1.30(3H,t,J=7Hz),3.14(2H,q,J=7Hz),6.70〜7.50(2
H,m), 9.70(1H,bs),10.27(1H,bs) 2−(2,4−ジフルオロフエニルアミノ)−5−フル
オロ−6−フエニルチオニコチン酸 融点;264〜265℃(再結溶媒;酢酸エチル:エタノール
=1:1) IR(KBr)cm-1;νc=o 1660 NMR(DMSO-d6)δ値; 6.00〜7.73(8H,m),7.85(1H,d,J=10Hz),10.58(1H,bs) 参考例9 6−(3−アセチルアミノ−1−ピロリジニル)−2−
(2,4−ジフルオロフエニルアミノ)−5−フルオロニ
コチン酸メチルエステル0.98gをテトラヒドロフラン
30m、メタノール10mおよび水4mの混合液
に懸濁させ、1N−水酸化ナトリウム水溶液5.3mを
加え、65℃で3時間反応させる。ついで、反応液を酢
酸エチル50mおよび水50mの混合液に加え、水
層を分取した後1N−塩酸でpH2.0に調整する。析出結
晶を取し、水2mおよびエタノール2mで順次洗
浄すれば、6−(3−アセチルアミノ−1−ピロリジニ
ル)−2−(2,4−ジフルオロフエニルアミノ)−5−
フルオロニコチン酸0.88g(収率93.0%)を得る。
これをアセトン−メタノール(容量比1:1)混合溶媒
で再結晶して融点233.5〜236℃を示す結晶を得る。
6-chloro-2- (2,4-difluorophenylamino) -5-fluoronicotinic acid Melting point; 226 to 228 ° C (resolving solvent; benzene) IR (KBr) cm -1 ; ν c = o 1680 NMR ( Acetone-d 6 ) δ value; 6.60〜7.41 (2H, m), 10.30 (1H, bs), 10.64 (1H, bs) 2- (2,4-difluorophenylamino) -5-fluoro-6- (2,4,6-trimethylbenzenesulfonyloxy) nicotinic acid Melting point; 179- 180 ° C (resolving solvent; benzene) IR (KBr) cm -1 ; ν c = o 1665 NMR (acetone-d 6 ) δ value; 2.32 (3H, s), 2.55 (6H, s), 2- (2,4-difluorophenylamino) -6-ethylthio-5-fluoronicotinic acid Melting point; 209 to 210 ° C (resolving solvent; benzene) IR (KBr) cm -1 ; ν c = o 1665 NMR ( Acetone-d 6 ) δ value; 1.30 (3H, t, J = 7Hz), 3.14 (2H, q, J = 7Hz), 6.70 to 7.50 (2
H, m), 9.70 (1H, bs), 10.27 (1H, bs) 2- (2,4-difluorophenylamino) -5-fluoro-6-phenylthionicotinic acid Melting point: 264-265 ° C (resolving solvent; ethyl acetate) : Ethanol = 1: 1) IR (KBr) cm −1 ; ν c = o 1660 NMR (DMSO-d 6 ) δ value; 6.00 to 7.73 (8H, m), 7.85 (1H, d, J = 10Hz), 10.58 (1H, bs) Reference Example 9 6- (3-Acetylamino-1-pyrrolidinyl) -2-
(2,4-Difluorophenylamino) -5-fluoronicotinic acid methyl ester 0.98 g was suspended in a mixed solution of tetrahydrofuran 30 m, methanol 10 m and water 4 m, and 1N-sodium hydroxide aqueous solution 5.3 m was added, React at 65 ° C. for 3 hours. Then, the reaction solution is added to a mixed solution of 50 m of ethyl acetate and 50 m of water, the aqueous layer is separated, and then adjusted to pH 2.0 with 1N-hydrochloric acid. The precipitated crystals were collected and washed successively with 2 m of water and 2 m of ethanol to give 6- (3-acetylamino-1-pyrrolidinyl) -2- (2,4-difluorophenylamino) -5-
0.888 g of fluoronicotinic acid (yield 93.0%) is obtained.
This is recrystallized with a mixed solvent of acetone-methanol (volume ratio 1: 1) to obtain a crystal having a melting point of 233.5 to 236 ° C.

IR(KBr)cm-1;νc=o 1645 NMR(TFA-d1)δ値; 3.62〜5.03(5H,m),6.82〜7.80(3H,m),8.27(1H,d,J=1
3Hz) 同様にして、つぎの化合物を得る。
IR (KBr) cm −1 ; ν c = o 1645 NMR (TFA-d 1 ) δ value; 3.62 to 5.03 (5H, m), 6.82 to 7.80 (3H, m), 8.27 (1H, d, J = 1
(3 Hz) Similarly, the following compound is obtained.

6−(4−アセチル−1−ピペラジニル)−2−(2,
4−ジフルオロフエニルアミノ)−5−フルオロニコチ
ン酸 融点;243〜244℃(再結溶媒;酢酸エチル:エタノール
=1:1) IR(KBr)cm-1;νc=o 1670,1635(sh) NMR(TFA-d1)δ値; 2.48(3H,s),3.47〜4.40(8H,m),6.83〜7.82(3H,m),8.
47(1H,d,J=13Hz) 参考例10 2−〔6−(3−アセチルアミノ−1−ピロリジニル)
−2−(2,4−ジフルオロフエニルアミノ)−5−フル
オロニコチノイル〕酢酸エチルエステル0.20gをベン
ゼン2mに懸濁させ、N,N−ジメチルホルムアミド
ジメチルアセタール0.10gを加え、加熱還流下で7時
間反応させる。ついで、析出結晶を取し、ジエチルエ
ーテル2mで洗浄すれば、7−(3−アセチルアミノ
−1−ピロリジニル)−1−(2,4−ジフルオロフエニ
ル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8
−ナフチリジン−3−カルボン酸エチルエステル0.18
g(収率88.1%)を得る。これをアセトン−メタノー
ル(容量比1:1)混合溶媒で再結晶して融点234〜236
℃を示す結晶を得る。
6- (4-acetyl-1-piperazinyl) -2- (2,
4-difluorophenylamino) -5-fluoronicotinic acid Melting point: 243 to 244 ° C (resolving solvent; ethyl acetate: ethanol = 1: 1) IR (KBr) cm −1 ; ν c = o 1670,1635 (sh ) NMR (TFA-d 1 ) δ value; 2.48 (3H, s), 3.47 to 4.40 (8H, m), 6.83 to 7.82 (3H, m), 8.
47 (1H, d, J = 13Hz) Reference Example 10 2- [6- (3-Acetylamino-1-pyrrolidinyl)
-2- (2,4-Difluorophenylamino) -5-fluoronicotinoyl] acetic acid ethyl ester (0.20 g) was suspended in benzene (2 m), N, N-dimethylformamide dimethylacetal (0.10 g) was added, and the mixture was heated under reflux. React under 7 hours. Then, the precipitated crystals were collected and washed with 2 m of diethyl ether to give 7- (3-acetylamino-1-pyrrolidinyl) -1- (2,4-difluorophenyl) -6-fluoro-1,4-dihydro. -4-oxo-1,8
-Naphthyridine-3-carboxylic acid ethyl ester 0.18
g (yield 88.1%) is obtained. This was recrystallized from a mixed solvent of acetone-methanol (volume ratio 1: 1) to give a melting point of 234-236.
Crystals showing ° C are obtained.

NMR(CDCl3)δ値; 1.33(3H,t,J=7Hz), 3.13〜4.02(4H,m), 6.78〜7.70(4H,m),8.10(1H,d,J=8Hz),8.31(1H,s) 参考例11 7−(3−アセチルアミノ−1−ピロリジニル)−1−
(2,4−ジフルオロフエニル)−6−フルオロ−1,4−ジ
ヒドロ−4−オキソ−1,8−ナフチリジン−3−カルボ
ン酸エチルエステル0.50gを6N−塩酸5mに溶解
させ、加熱還流下で4時間反応させる。ついで、析出結
晶を取し、水1mで洗浄すれば7−(3−アミノ−
1−ピロリジニル)−1−(2,4−ジフルオロフエニ
ル)−6−フルオロ−1,4−ジヒドロ−4−オキソ−1,8
−ナフチリジン−3−カルボン酸の塩酸塩0.39g(収
率84.0%)を得る。これを濃塩酸−エタノール(容量
比1:3)混合溶媒で再結晶して融点247〜250℃(分
解)を示す結晶を得る。
NMR (CDCl 3 ) δ value; 1.33 (3H, t, J = 7Hz), 3.13 ~ 4.02 (4H, m), 6.78 to 7.70 (4H, m), 8.10 (1H, d, J = 8Hz), 8.31 (1H, s) Reference Example 11 7- (3-Acetylamino-1-pyrrolidinyl) -1-
(2,4-Difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid ethyl ester 0.50 g was dissolved in 6 N-hydrochloric acid 5 m and heated under reflux. Allow to react for 4 hours under. Then, the precipitated crystals are collected and washed with 1 m of water to obtain 7- (3-amino-
1-pyrrolidinyl) -1- (2,4-difluorophenyl) -6-fluoro-1,4-dihydro-4-oxo-1,8
0.39 g (yield 84.0%) of the hydrochloride of naphthyridine-3-carboxylic acid is obtained. This is recrystallized with a mixed solvent of concentrated hydrochloric acid-ethanol (volume ratio 1: 3) to obtain crystals having a melting point of 247 to 250 ° C (decomposition).

NMR(TFA-d1)δ値; 2.23〜2.95(2H,m),3.38〜4.83(5H,m),6.95〜7.90(3H,
m),8.22(1H,d,J=11Hz),9.18(1H,s) 参考例12 参考例10および11と同様にして、つぎの化合物を得
る。
NMR (TFA-d 1 ) δ value; 2.23 to 2.95 (2H, m), 3.38 to 4.83 (5H, m), 6.95 to 7.90 (3H,
m), 8.22 (1H, d, J = 11Hz), 9.18 (1H, s) Reference Example 12 In the same manner as in Reference Examples 10 and 11, the following compound was obtained.

1−(2,4−ジフルオロフエニル)−6−フルオロ−
1,4−ジヒドロ−4−オキソ−7−(1−ピペラジニ
ル)−1,8−ナフチリジン−3−カルボン酸の塩酸塩 融点;249〜252℃(分解)(再結溶媒;濃塩酸:メタノ
ール=1:2) NMR(TFA-d1)δ値; 3.33〜3.92(4H,m),3.92〜4.50(4H,m),6.90〜7.90(3H,
m),8.30(1H,d,J=12Hz),9.18(1H,s)
1- (2,4-difluorophenyl) -6-fluoro-
Hydrochloride of 1,4-dihydro-4-oxo-7- (1-piperazinyl) -1,8-naphthyridine-3-carboxylic acid Melting point: 249-252 ° C (decomposition) (resolving solvent; concentrated hydrochloric acid: methanol = 1: 2) NMR (TFA-d 1 ) δ value; 3.33 to 3.92 (4H, m), 3.92 to 4.50 (4H, m), 6.90 to 7.90 (3H,
m), 8.30 (1H, d, J = 12Hz), 9.18 (1H, s)

───────────────────────────────────────────────────── フロントページの続き (72)発明者 小西 義憲 富山県高岡市佐加野(佐加野新町)1000― 72 (72)発明者 成田 弘和 富山県富山市奥田本町6―40 (72)発明者 高野 俊太郎 富山県富山市稲荷元町3丁目8―44 (72)発明者 才川 勇 富山県富山市大泉中町7―52 審査官 赤坂 信一 ─────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Yoshinori Konishi Sano (Takaoka Shinmachi), Takaoka City, Toyama 1000-72 (72) Inventor Hirokazu Narita 6-40, Okudahonmachi, Toyama City, Toyama (72) Inventor Takano Shuntaro 3-8-44, Inarimoto-cho, Toyama-shi, Toyama (72) Inventor Isamu Saikawa 7-52 Oizumi-naka-cho, Toyama-shi, Toyama Examiner Shinichi Akasaka

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】一般式 で表わされる2−(5−フルオロニコチノイル)酢酸誘
導体およびその塩。
1. A general formula A 2- (5-fluoronicotinoyl) acetic acid derivative represented by and a salt thereof.
JP60028397A 1985-01-23 1985-02-18 2- (5-fluoronicotinoyl) acetic acid derivative and its salt Expired - Lifetime JPH0629246B2 (en)

Priority Applications (50)

Application Number Priority Date Filing Date Title
JP60028397A JPH0629246B2 (en) 1985-02-18 1985-02-18 2- (5-fluoronicotinoyl) acetic acid derivative and its salt
AT72/86A AT392789B (en) 1985-01-23 1986-01-14 METHOD FOR PRODUCING 1-SUBSTITUTED ARYL-1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES
GB8601045A GB2170804B (en) 1985-01-23 1986-01-16 Novel process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative, intermediates thereof and processes for producing the intermediates
US06/819,821 US4704459A (en) 1985-01-23 1986-01-17 Process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivatives, and processes for producing the intermediates
DE19863601517 DE3601517A1 (en) 1985-01-23 1986-01-20 NEW METHOD FOR PRODUCING 1-SUBST.-ARYL-1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES, INTERMEDIATE PRODUCTS THEREOF AND METHOD FOR PRODUCING THE INTERIM PRODUCTS
FI860250A FI83313C (en) 1985-01-23 1986-01-20 New process for the preparation of 1- (substituted aryl) -1,4-dihydro-4-oxo-1,8-naphthyridine derivatives and intermediates useful in the process
DE3641633A DE3641633C2 (en) 1985-01-23 1986-01-20 New 5-fluoronicotinic acid derivatives, their salts and reactive derivatives of the carboxyl group thereof
DE3637679A DE3637679C1 (en) 1985-01-23 1986-01-20 2- (5-fluoronicotinoyl) acetic acid derivatives and process for their preparation
AU52543/86A AU576657B2 (en) 1985-01-23 1986-01-21 Naphthyridine and pyridine derivatives
CH235/86A CH667456A5 (en) 1985-01-23 1986-01-22 METHOD FOR PRODUCING 1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES CARRYING A SUBSTITUTED ARYL REST IN 1-POSITION.
NZ214901A NZ214901A (en) 1985-01-23 1986-01-22 Naphthyridine derivatives and nicotinic acid derivative intermediates
NO860226A NO163227C (en) 1985-01-23 1986-01-22 PROCEDURE TE FOR PREPARATION OF 1-SUBSTITUTED-ARYI HYDRO-4-OXONAFTYRIDINE DERIVATIVES.
FR868600871A FR2576305B1 (en) 1985-01-23 1986-01-22 NOVEL PROCESS FOR THE MANUFACTURE OF A DERIVATIVE OF (SUBSTITUTED ARYL) -1 DIHYDRO-1,4 OXO-4 NAPHTYRIDINE, INTERMEDIATE SUBSTANCES USED FOR THIS MANUFACTURE AND METHODS OF MANUFACTURE OF INTERMEDIATE SUBSTANCES
DK032286A DK169570B1 (en) 1985-01-23 1986-01-22 Process for the preparation of 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivatives
NL8600138A NL192986C (en) 1985-01-23 1986-01-22 Process for preparing 1,4-dihydro-4-oxo-naphthyridine derivatives.
CH643/88A CH671957A5 (en) 1985-01-23 1986-01-22
SE8600274A SE462164B (en) 1985-01-23 1986-01-22 PROCEDURES FOR PREPARING 1-SUBSTITUTED ARYL-1,4-DIHYDRO-4-OXONAFTYRIDE DERIVATIVES
ES551134A ES8702362A1 (en) 1985-01-23 1986-01-22 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn.
CA000500107A CA1340706C (en) 1985-01-23 1986-01-22 Process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and processes for producing the intermediates
BE0/216165A BE904086A (en) 1985-01-23 1986-01-22 NOVEL PROCESS FOR THE MANUFACTURE OF A DERIVATIVE OF (SUBSTITUTED ARYL) -1 DIHYDRO-1,4 OXO-4 NAPHTYRIDINE INTERMEDIATE SUBSTANCES USED FOR THIS MANUFACTURE AND METHODS OF MANUFACTURE OF INTERMEDIATE SUBSTANCES.
CN 86100879 CN1019012B (en) 1985-01-23 1986-01-22 Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative intermediates
PT81889A PT81889B (en) 1985-01-23 1986-01-22 PROCESS FOR THE PREPARATION OF POSITION 1 SUBSTITUTED ARIL-1,4-DIHIDRO-4-OXONETHRIDIDINE DERIVATIVES AND INTERMEDIATE COMPOUNDS USED IN THAT PROCESS
KR1019860000388A KR880001078B1 (en) 1985-01-23 1986-01-22 Process for the preparation of 1-substituted arye-1,4-dihydro-4-oxonaphthyridine derivatives
PH33316A PH22711A (en) 1985-01-23 1986-01-22 Novel process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivative, intermediates thereof and processes for producing the intermediates
IT47562/86A IT1190193B (en) 1985-01-23 1986-01-22 PROCEDURE FOR THE PRODUCTION OF AN ARIL-1,4-DIHYDRO-4-OSSONAFTYRIDINE 1-SUBSTITUTE DERIVATIVE, INTERMEDIATE FOR THE SAME, AND PROCEDURES FOR THE PRODUCTION OF INTERMEDIATES
IL88468A IL88468A (en) 1985-01-23 1986-01-23 2-(4-fluoro or 2,4-difluorophenylamino)-5-fluoro-6-substituted nicotinic acid and nicotinyl acetic acid and their preparation
LU86264A LU86264A1 (en) 1985-01-23 1986-01-23 NOVEL PROCESS FOR THE PREPARATION OF A DERIVATIVE OF ARYL-1,4-DIHYDRO 4-OXONAPHTYRIDINE 1-SUBSTITUTED INTERMEDIATE PRODUCTS FOR THIS DERIVATIVE AND PROCESS FOR THE PREPARATION OF INTERMEDIATE PRODUCTS
IL9240186A IL92401A (en) 1985-01-23 1986-01-23 Process for producing 7-halogeno-1-(4-fluoro or 2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivative
IL77688A IL77688A (en) 1985-01-23 1986-01-23 Process for producing 7-substituted-6-fluoro-1-(4-fluoro or 2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and some new such derivatives produced thereby
ES557077A ES8707730A1 (en) 1985-01-23 1986-09-19 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn.
ES557078A ES8707715A1 (en) 1985-01-23 1986-09-19 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn.
PH35456A PH22956A (en) 1985-01-23 1987-06-25 Fluoronicotinic avid derivatives and process of preparing said compounds
PH35456A PH23202A (en) 1985-01-23 1987-06-25 2-(5-fluoronicotinoyl) acetic acid derivatives and process of preparation thereof
US06/067,264 US4851535A (en) 1985-01-23 1987-06-29 Nicotinic acid derivatives
CH642/88A CH669378A5 (en) 1985-01-23 1988-01-22 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn.
GB8811645A GB2204040B (en) 1985-01-23 1988-05-17 2-(5-fluoronicotinoyl)-acetic acid intermediates
CA 568266 CA1340648C (en) 1985-01-23 1988-05-31 Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and porcesses for producing the intermediates
CA000568265A CA1340783C (en) 1985-01-23 1988-05-31 Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and processes for producing the intermediates
SE8902265A SE469984B (en) 1985-01-23 1989-06-21 5-Fluoronicotinic acid derivative and process for its preparation
SE8902264A SE469983B (en) 1985-01-23 1989-06-21 2- (5-Fluoronicotinoyl) -acetic acid derivatives and process for their preparation
FI893074A FI85703C (en) 1985-01-23 1989-06-22 FOERFARANDE FOER FRAMSTAELLNING AV 1,4 -DIHYDRO-4-OXONAFTYRIDINDERIVAT.
FI893075A FI87647C (en) 1985-01-23 1989-06-22 FAR OIL FRAMSTERING AV NYA 5-FLUORNICOTIN SYROR ELLER FOR CARBOXYL GROUP DETERMINING REACTIVE DERIVATIVES DAERAV ELLER SALTER DAERAV OCH DERAS MELLANPRODUKTER
NO892692A NO174888C (en) 1985-01-23 1989-06-28 New 2- (5-fluoro-nicotinoyl) -acetic acid derivatives
NO892693A NO167804C (en) 1985-01-23 1989-06-28 PROCEDURE FOR THE PREPARATION OF 1-SUBSTITUTED-PHENYL-1,4-DIHYDRO-4-OXONAFTYRIDINE DERIVATIVES.
AT2003/89A AT392791B (en) 1985-01-23 1989-08-24 Process for the preparation of 1-substituted aryl-1,4- dihydro-4-oxonaphthyridine derivatives
AT0200289A AT394193B (en) 1985-01-23 1989-08-24 Process for the preparation of novel 5-fluoronicotinic acids or derivatives and salts thereof
DK285290A DK170532B1 (en) 1985-01-23 1990-11-30 5-Fluornicotinic acid derivative or salt thereof or reactive derivative in the carboxyl group thereof
DK285190A DK170857B1 (en) 1985-01-23 1990-11-30 2- (5-Fluornicotinoyl) acetic acid derivative and process for its preparation
NO924181A NO178574C (en) 1985-01-23 1992-10-29 New 5-fluoronicotinic acid derivatives
NL9700011A NL193540C (en) 1985-01-23 1997-11-06 Method for preparing nicotinic acid derivatives.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60028397A JPH0629246B2 (en) 1985-02-18 1985-02-18 2- (5-fluoronicotinoyl) acetic acid derivative and its salt

Publications (2)

Publication Number Publication Date
JPS61189269A JPS61189269A (en) 1986-08-22
JPH0629246B2 true JPH0629246B2 (en) 1994-04-20

Family

ID=12247527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60028397A Expired - Lifetime JPH0629246B2 (en) 1985-01-23 1985-02-18 2- (5-fluoronicotinoyl) acetic acid derivative and its salt

Country Status (1)

Country Link
JP (1) JPH0629246B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics

Also Published As

Publication number Publication date
JPS61189269A (en) 1986-08-22

Similar Documents

Publication Publication Date Title
US4704459A (en) Process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivatives, and processes for producing the intermediates
US4851535A (en) Nicotinic acid derivatives
JPH0629246B2 (en) 2- (5-fluoronicotinoyl) acetic acid derivative and its salt
JPH0629247B2 (en) 5-fluoronicotinic acid derivative and its salt
US4921953A (en) Cephalosporin derivatives
KR870000528B1 (en) Process for preparing 3-azidocephalosporins
US4699981A (en) Cephalosporin derivatives
JPH0665672B2 (en) Novel process for producing 1,4-dihydro-4-oxonaphthyridine derivative or salt thereof
US5416081A (en) Cephalosporin compounds
NO883219L (en) PROCEDURE FOR THE PREPARATION OF BETA-LACTAM COMPOUND, INTERMEDIATE PRODUCT FOR THE PREPARATION OF IT, AND MEDICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIOLOGICAL INFECTIOUS DISEASES CONTAINING THIS.
JPH0285255A (en) Quinolonecarboxylic acid derivative or its salt
JPH0665670B2 (en) 1,4-Dihydro-4-oxonaphthyridine derivatives and salts thereof
IL44360A (en) 7-acylamido-3-hydroxy-3-cephem-4-carboxylic acid 3-sulfonates
JPH0662619B2 (en) Novel process for producing 1,4-dihydro-4-oxonaphthyridine derivative or salt thereof
JPH0665671B2 (en) Novel process for producing 1-substituted aryl-1,4-dihydro-4-oxonaphthyridine derivative or salt thereof
JPH0832707B2 (en) Novel cephalosporins and their salts
US4841044A (en) Cephalosporin derivatives
CA1340648C (en) Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative, intermediates therefor and porcesses for producing the intermediates
FI85703B (en) Method for manufacture of 1,4-dihydro-4-oxonaphthyridine derivatives
NO174888B (en) New 2- (5-fluoro-nicotinoyl) -acetic acid derivatives
DE3641633C2 (en) New 5-fluoronicotinic acid derivatives, their salts and reactive derivatives of the carboxyl group thereof
JPH072714B2 (en) 5-fluoronicotinic acid derivative and its salt
JPH07116154B2 (en) Reactive derivatives at the carboxyl group of new 5-fluoronicotinic acids
CH669378A5 (en) 1-Fluoro:phenyl-1,8-naphthyridine-3-carboxylic acid derivs. prodn.
JPH01283288A (en) Novel penam derivative and salt thereof

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term